Year |
Citation |
Score |
2024 |
Soldan A, Wang J, Pettigrew C, Davatzikos C, Erus G, Hohman TJ, Dumitrescu L, Bilgel M, Resnick SM, Rivera-Rivera LA, Langhough R, Johnson SC, Benzinger T, Morris JC, Laws SM, ... ... Albert MS, et al. Alzheimer's disease genetic risk and changes in brain atrophy and white matter hyperintensities in cognitively unimpaired adults. Brain Communications. 6: fcae276. PMID 39229494 DOI: 10.1093/braincomms/fcae276 |
0.39 |
|
2024 |
Liu P, Lin Z, Hazel K, Pottanat G, Xu C, Jiang D, Pillai JJ, Lucke E, Bauer CE, Gold BT, Greenberg SM, Helmer KG, Jann K, Jicha G, Kramer J, ... ... Albert M, et al. Cerebrovascular reactivity MRI as a biomarker for cerebral small vessel disease-related cognitive decline: Multi-site validation in the MarkVCID Consortium. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 38951718 DOI: 10.1002/alz.13888 |
0.301 |
|
2024 |
Sur S, Lin Z, Li Y, Yasar S, Rosenberg PB, Moghekar A, Hou X, Jiang D, Kalyani RR, Hazel K, Pottanat G, Xu C, Pillai JJ, Liu P, Albert M, et al. CO cerebrovascular reactivity measured with CBF-MRI in older individuals: Association with cognition, physical function, amyloid, and tau proteins. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X241240582. PMID 38489769 DOI: 10.1177/0271678X241240582 |
0.362 |
|
2024 |
Mohs R, Bakker A, Rosenzweig-Lipson S, Rosenblum M, Barton RL, Albert MS, Cohen S, Zeger S, Gallagher M. The HOPE4MCI study: A randomized double-blind assessment of AGB101 for the treatment of MCI due to AD. Alzheimer's & Dementia (New York, N. Y.). 10: e12446. PMID 38356475 DOI: 10.1002/trc2.12446 |
0.378 |
|
2023 |
Rani N, Alm KH, Corona-Long CA, Speck CL, Soldan A, Pettigrew C, Zhu Y, Albert M, Bakker A. Tau PET burden in Brodmann areas 35 and 36 is associated with individual differences in cognition in non-demented older adults. Frontiers in Aging Neuroscience. 15: 1272946. PMID 38161595 DOI: 10.3389/fnagi.2023.1272946 |
0.323 |
|
2023 |
Bahrani AA, Abner EL, DeCarli CS, Barber JM, Sutton AC, Maillard P, Sandoval F, Arfanakis K, Yang YC, Evia AM, Schneider JA, Habes M, Franklin CG, Seshadri S, Satizabal CL, ... ... Albert MS, et al. Multi-Site Cross-Site Inter-Rater and Test-Retest Reliability and Construct Validity of the MarkVCID White Matter Hyperintensity Growth and Regression Protocol. Journal of Alzheimer's Disease : Jad. PMID 37840499 DOI: 10.3233/JAD-230629 |
0.311 |
|
2023 |
Sun Y, Moghekar A, Soldan A, Pettigrew C, Greenberg B, Albert M, Wang MC. Cerebrospinal Fluid Alzheimer's Disease Biomarker Patterns of Change Prior to the Onset of Mild Cognitive Impairment. Journal of Alzheimer's Disease : Jad. PMID 37742656 DOI: 10.3233/JAD-230807 |
0.348 |
|
2023 |
Kamalian A, Ho SG, Patel M, Lewis A, Bakker A, Albert M, O'Brien RJ, Moghekar A, Lutz MW. Exploratory Assessment of Proteomic Network Changes in Cerebrospinal Fluid of Mild Cognitive Impairment Patients: A Pilot Study. Biomolecules. 13. PMID 37509130 DOI: 10.3390/biom13071094 |
0.326 |
|
2023 |
Rajabli F, Benchek P, Tosto G, Kushch N, Sha J, Bazemore K, Zhu C, Lee WP, Haut J, Hamilton-Nelson KL, Wheeler NR, Zhao Y, Farrell JJ, Grunin MA, Leung YY, ... ... Albert MS, et al. Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies and nominates ancestry-specific loci , , and as novel risk loci for Alzheimer's disease: the Alzheimer's Disease Genetics Consortium. Medrxiv : the Preprint Server For Health Sciences. PMID 37461624 DOI: 10.1101/2023.07.06.23292311 |
0.458 |
|
2023 |
Soldan A, Oh S, Ryu T, Pettigrew C, Zhu Y, Moghekar A, Xiao MF, Pontone GM, Albert M, Na CH, Worley P. NPTX2 in cerebrospinal fluid predicts the progression from normal cognition to Mild Cognitive Impairment. Annals of Neurology. PMID 37345460 DOI: 10.1002/ana.26725 |
0.326 |
|
2023 |
Pettigrew C, Nazarovs J, Soldan A, Singh V, Wang J, Hohman T, Dumitrescu L, Libby J, Kunkle B, Gross AL, Johnson S, Lu Q, Engelman C, Masters CL, Maruff P, ... ... Albert M, et al. Alzheimer's disease genetic risk and cognitive reserve in relationship to long-term cognitive trajectories among cognitively normal individuals. Alzheimer's Research & Therapy. 15: 66. PMID 36978190 DOI: 10.1186/s13195-023-01206-9 |
0.321 |
|
2023 |
Stouffer KM, Chen C, Kulason S, Xu E, Witter MP, Ceritoglu C, Albert MS, Mori S, Troncoso J, Tward DJ, Miller MI. Early amygdala and ERC atrophy linked to 3D reconstruction of rostral neurofibrillary tau tangle pathology in Alzheimer's disease. Neuroimage. Clinical. 38: 103374. PMID 36934675 DOI: 10.1016/j.nicl.2023.103374 |
0.348 |
|
2023 |
Newton P, Tchounguen J, Pettigrew C, Lim C, Lin Z, Lu H, Moghekar A, Albert M, Soldan A. Regional White Matter Hyperintensities and Alzheimer's Disease Biomarkers Among Older Adults with Normal Cognition and Mild Cognitive Impairment. Journal of Alzheimer's Disease : Jad. PMID 36744337 DOI: 10.3233/JAD-220846 |
0.39 |
|
2022 |
Pettigrew C, Soldan A, Wang J, Wang MC, Greenberg B, Albert M, Moghekar A. Longitudinal CSF Alzheimer's disease biomarker changes from middle age to late adulthood. Alzheimer's & Dementia (Amsterdam, Netherlands). 14: e12374. PMID 36415591 DOI: 10.1002/dad2.12374 |
0.351 |
|
2022 |
Greenberg BD, Pettigrew C, Soldan A, Wang J, Wang MC, Darrow JA, Albert MS, Moghekar A. CSF Alzheimer Disease Biomarkers: Time-Varying Relationships With MCI Symptom Onset and Associations With Age, Sex, and . Neurology. 99: e1640-e1650. PMID 36216518 DOI: 10.1212/WNL.0000000000200953 |
0.339 |
|
2022 |
Luo J, Agboola F, Grant E, Morris JC, Masters CL, Albert MS, Johnson SC, McDade EM, Fagan AM, Benzinger TLS, Hassenstab J, Bateman RJ, Perrin RJ, Wang G, Li Y, et al. Accelerated longitudinal changes and ordering of Alzheimer disease biomarkers across the adult lifespan. Brain : a Journal of Neurology. PMID 35925685 DOI: 10.1093/brain/awac238 |
0.363 |
|
2022 |
Hwang G, Abdulkadir A, Erus G, Habes M, Pomponio R, Shou H, Doshi J, Mamourian E, Rashid T, Bilgel M, Fan Y, Sotiras A, Srinivasan D, Morris JC, Albert MS, et al. Disentangling Alzheimer's disease neurodegeneration from typical brain ageing using machine learning. Brain Communications. 4: fcac117. PMID 35611306 DOI: 10.1093/braincomms/fcac117 |
0.361 |
|
2021 |
Pettigrew C, Soldan A, Brichko R, Zhu Y, Wang MC, Kutten K, Bilgel M, Mori S, Miller MI, Albert M. Computerized paired associate learning performance and imaging biomarkers in older adults without dementia. Brain Imaging and Behavior. PMID 34686968 DOI: 10.1007/s11682-021-00583-9 |
0.321 |
|
2021 |
Byeon SK, Madugundu AK, Jain AP, Bhat FA, Jung JH, Renuse S, Darrow J, Bakker A, Albert M, Moghekar A, Pandey A. Cerebrospinal fluid lipidomics for biomarkers of Alzheimer's disease. Molecular Omics. 17: 454-463. PMID 34125126 DOI: 10.1039/d0mo00186d |
0.317 |
|
2021 |
Wilcock D, Jicha G, Blacker D, Albert MS, D'Orazio LM, Elahi FM, Fornage M, Hinman JD, Knoefel J, Kramer J, Kryscio RJ, Lamar M, Moghekar A, Prestopnik J, Ringman JM, et al. MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 33480172 DOI: 10.1002/alz.12215 |
0.305 |
|
2020 |
Chan CK, Soldan A, Pettigrew C, Wang J, Albert M, Rosenberg PB. Depressive symptoms and CSF Alzheimer's disease biomarkers in relation to clinical symptom onset of mild cognitive impairment. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12106. PMID 33005725 DOI: 10.1002/dad2.12106 |
0.321 |
|
2020 |
Pettigrew C, Soldan A, Wang J, Wang MC, Arthur K, Moghekar A, Gottesman RF, Albert M. Association of midlife vascular risk and AD biomarkers with subsequent cognitive decline. Neurology. PMID 32989109 DOI: 10.1212/WNL.0000000000010946 |
0.302 |
|
2020 |
Kulason S, Xu E, Tward DJ, Bakker A, Albert M, Younes L, Miller MI. Entorhinal and Transentorhinal Atrophy in Preclinical Alzheimer's Disease. Frontiers in Neuroscience. 14: 804. PMID 32973425 DOI: 10.3389/Fnins.2020.00804 |
0.388 |
|
2020 |
Habes M, Pomponio R, Shou H, Doshi J, Mamourian E, Erus G, Nasrallah I, Launer LJ, Rashid T, Bilgel M, Fan Y, Toledo JB, Yaffe K, Sotiras A, Srinivasan D, ... ... Albert MS, et al. The Brain Chart of Aging: Machine-learning analytics reveals links between brain aging, white matter disease, amyloid burden, and cognition in the iSTAGING consortium of 10,216 harmonized MR scans. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32920988 DOI: 10.1002/Alz.12178 |
0.431 |
|
2020 |
Luo J, Agboola F, Grant E, Masters CL, Albert MS, Johnson SC, McDade EM, Vöglein J, Fagan AM, Benzinger T, Massoumzadeh P, Hassenstab J, Bateman RJ, Morris JC, Perrin RJ, et al. Sequence of Alzheimer disease biomarker changes in cognitively normal adults: A cross-sectional study. Neurology. PMID 32873693 DOI: 10.1212/Wnl.0000000000010747 |
0.455 |
|
2020 |
Soldan A, Pettigrew C, Zhu Y, Wang MC, Gottesman RF, DeCarli C, Albert M. Cognitive reserve and midlife vascular risk: Cognitive and clinical outcomes. Annals of Clinical and Translational Neurology. 7: 1307-1317. PMID 32856790 DOI: 10.1002/Acn3.51120 |
0.371 |
|
2020 |
Wang Z, Tang Z, Zhu Y, Pettigrew C, Soldan A, Gross A, Albert M. AD risk score for the early phases of disease based on unsupervised machine learning. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32729964 DOI: 10.1002/Alz.12140 |
0.426 |
|
2020 |
Sur S, Lin Z, Li Y, Yasar S, Rosenberg P, Moghekar A, Hou X, Kalyani R, Hazel K, Pottanat G, Xu C, van Zijl P, Pillai J, Liu P, Albert M, et al. Association of cerebrovascular reactivity and Alzheimer pathologic markers with cognitive performance. Neurology. PMID 32661101 DOI: 10.1212/Wnl.0000000000010133 |
0.465 |
|
2020 |
Sathe G, Albert M, Darrow J, Saito A, Troncoso J, Pandey A, Moghekar A. Quantitative proteomic analysis of the frontal cortex in Alzheimer's disease. Journal of Neurochemistry. PMID 32614981 DOI: 10.1111/Jnc.15116 |
0.385 |
|
2020 |
Bashyam VM, Erus G, Doshi J, Habes M, Nasralah I, Truelove-Hill M, Srinivasan D, Mamourian L, Pomponio R, Fan Y, Launer LJ, Masters CL, Maruff P, Zhuo C, Völzke H, ... ... Albert MS, et al. MRI signatures of brain age and disease over the lifespan based on a deep brain network and 14 468 individuals worldwide. Brain : a Journal of Neurology. PMID 32591831 DOI: 10.1093/Brain/Awaa160 |
0.309 |
|
2020 |
Raghavan NS, Dumitrescu L, Mormino E, Mahoney ER, Lee AJ, Gao Y, Bilgel M, Goldstein D, Harrison T, Engelman CD, Saykin AJ, Whelan CD, Liu JZ, Jagust W, Albert M, et al. Association Between Common Variants in RBFOX1, an RNA-Binding Protein, and Brain Amyloidosis in Early and Preclinical Alzheimer Disease. Jama Neurology. PMID 32568366 DOI: 10.1001/Jamaneurol.2020.1760 |
0.489 |
|
2020 |
Jiang D, Lin Z, Liu P, Sur S, Xu C, Hazel K, Pottanat G, Darrow J, Pillai JJ, Yasar S, Rosenberg P, Moghekar A, Albert M, Lu H. Brain Oxygen Extraction Is Differentially Altered by Alzheimer's and Vascular Diseases. Journal of Magnetic Resonance Imaging : Jmri. PMID 32567195 DOI: 10.1002/Jmri.27264 |
0.442 |
|
2020 |
Cable J, Holtzman DM, Hyman BT, Tansey MG, Colonna M, Kellis M, Brinton RD, Albert M, Wellington CL, Sisodia SS, Tanzi RE. Alternatives to amyloid for Alzheimer's disease therapies-a symposium report. Annals of the New York Academy of Sciences. PMID 32472577 DOI: 10.1111/Nyas.14371 |
0.388 |
|
2020 |
Soldan A, Pettigrew C, Albert M. Cognitive Reserve from the Perspective of Preclinical Alzheimer Disease: 2020 Update. Clinics in Geriatric Medicine. 36: 247-263. PMID 32222300 DOI: 10.1016/J.Cger.2019.11.006 |
0.436 |
|
2020 |
Koychev I, Vaci N, Bilgel M, An Y, Muniz GT, Wong DF, Gallacher J, Mogekhar A, Albert M, Resnick SM. Prediction of rapid amyloid and phospotylated-Tau accumulation in cognitively healthy individuals. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12019. PMID 32211504 DOI: 10.1002/Dad2.12019 |
0.458 |
|
2020 |
Sathe G, Mangalaparthi KK, Jain A, Darrow J, Troncoso J, Albert M, Moghekar A, Pandey A. Multiplexed Phosphoproteomic Study of Brain in Patients with Alzheimer's Disease and Age-Matched Cognitively Healthy Controls. Omics : a Journal of Integrative Biology. PMID 32182160 DOI: 10.1089/Omi.2019.0191 |
0.427 |
|
2020 |
Allnutt MA, Johnson K, Bennett DA, Connor SM, Troncoso JC, Pletnikova O, Albert MS, Resnick SM, Scholz SW, De Jager PL, Jacobson S. Human Herpesvirus 6 Detection in Alzheimer's Disease Cases and Controls across Multiple Cohorts. Neuron. PMID 31983538 DOI: 10.1016/J.Neuron.2019.12.031 |
0.365 |
|
2020 |
Walker KA, Gross AL, Moghekar AR, Soldan A, Pettigrew C, Hou X, Lu H, Alfini AJ, Bilgel M, Miller MI, Albert MS, Walston J. Association of peripheral inflammatory markers with connectivity in large-scale functional brain networks of non-demented older adults. Brain, Behavior, and Immunity. PMID 31935468 DOI: 10.1016/J.Bbi.2020.01.006 |
0.378 |
|
2020 |
Xiong C, Luo J, Masters CL, Johnson SC, Albert MS, McDade E, Fagan AM, Benzinger TL, Hassenstab J, Cruchaga C, Bateman RJ, Morris JC. Orderings of biomarker changes for Alzheimer disease in cognitively normal individuals from 18 to 101 years of age Alzheimer's & Dementia. 16. DOI: 10.1002/alz.043187 |
0.323 |
|
2019 |
Pettigrew C, Soldan A, Zhu Y, Cai Q, Wang MC, Moghekar A, Miller MI, Singh B, Martinez O, Fletcher E, DeCarli C, Albert M. Cognitive reserve and rate of change in Alzheimer's and cerebrovascular disease biomarkers among cognitively normal individuals. Neurobiology of Aging. PMID 31932050 DOI: 10.1016/J.Neurobiolaging.2019.12.003 |
0.444 |
|
2019 |
Soldan A, Pettigrew C, Zhu Y, Wang MC, Moghekar A, Gottesman RF, Singh B, Martinez O, Fletcher E, DeCarli C, Albert M. White matter hyperintensities and CSF Alzheimer disease biomarkers in preclinical Alzheimer disease. Neurology. PMID 31888969 DOI: 10.1212/Wnl.0000000000008864 |
0.483 |
|
2019 |
Alm KH, Faria AV, Moghekar A, Pettigrew C, Soldan A, Mori S, Albert M, Bakker A. Medial temporal lobe white matter pathway variability is associated with individual differences in episodic memory in cognitively normal older adults. Neurobiology of Aging. PMID 31874745 DOI: 10.1016/J.Neurobiolaging.2019.11.011 |
0.397 |
|
2019 |
Blauwendraat C, Reed X, Krohn L, Heilbron K, Bandres-Ciga S, Tan M, Gibbs JR, Hernandez DG, Kumaran R, Langston R, Bonet-Ponce L, Alcalay RN, Hassin-Baer S, Greenbaum L, Iwaki H, ... ... Albert MS, et al. Genetic modifiers of risk and age at onset in GBA associated Parkinson's disease and Lewy body dementia. Brain : a Journal of Neurology. PMID 31755958 DOI: 10.1093/Brain/Awz350 |
0.338 |
|
2019 |
Hou X, Liu P, Li Y, Jiang D, De Vis JB, Lin Z, Sur S, Baker Z, Mao D, Ravi H, Rodrigue K, Albert M, Park DC, Lu H. The association between BOLD-based cerebrovascular reactivity (CVR) and end-tidal CO in healthy subjects. Neuroimage. 116365. PMID 31734432 DOI: 10.1016/J.Neuroimage.2019.116365 |
0.301 |
|
2019 |
Gross AL, Walker KA, Moghekar AR, Pettigrew C, Soldan A, Albert MS, Walston JD. Plasma Markers of Inflammation Linked to Clinical Progression and Decline During Preclinical AD. Frontiers in Aging Neuroscience. 11: 229. PMID 31555121 DOI: 10.3389/Fnagi.2019.00229 |
0.393 |
|
2019 |
Xiong C, Luo J, Agboola F, Li Y, Albert M, Johnson SC, Koscik RL, Masters CL, Soldan A, Villemagne VL, Li QX, McDade EM, Fagan AM, Massoumzadeh P, Benzinger T, et al. A harmonized longitudinal biomarkers and cognition database for assessing the natural history of preclinical Alzheimer's disease from young adulthood and for designing prevention trials. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31506247 DOI: 10.1016/J.Jalz.2019.06.4955 |
0.466 |
|
2019 |
Dumitrescu L, Barnes LL, Thambisetty M, Beecham G, Kunkle B, Bush WS, Gifford KA, Chibnik LB, Mukherjee S, De Jager PL, Kukull W, Crane PK, Resnick SM, Keene CD, Montine TJ, ... ... Albert M, et al. Sex differences in the genetic predictors of Alzheimer's pathology. Brain : a Journal of Neurology. 142: 2581-2589. PMID 31497858 DOI: 10.1093/Brain/Awz206 |
0.378 |
|
2019 |
Coughlin JM, Rubin LH, Du Y, Rowe SP, Crawford JL, Rosenthal HB, Frey SM, Marshall ES, Shinehouse LK, Chen A, Speck CL, Wang Y, Lesniak WG, Minn I, Bakker A, ... ... Albert MS, et al. High availability of the α7 nicotinic acetylcholine receptor in brains of individuals with mild cognitive impairment: A pilot study using F-ASEM PET. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 31420499 DOI: 10.2967/Jnumed.119.230979 |
0.345 |
|
2019 |
Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A, Bellenguez C, Frizatti A, Chouraki V, Martin ER, Sleegers K, ... ... Albert MS, et al. Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nature Genetics. PMID 31417202 DOI: 10.1038/s41588-019-0495-7 |
0.451 |
|
2019 |
Liu CF, Padhy S, Ramachandran S, Wang VX, Efimov A, Bernal A, Shi L, Vaillant M, Ratnanather JT, Faria AV, Caffo B, Albert M, Miller MI. Using Deep Siamese Neural Networks for Detection of Brain Asymmetries Associated with Alzheimer's Disease and Mild Cognitive Impairment. Magnetic Resonance Imaging. PMID 31319126 DOI: 10.1016/J.Mri.2019.07.003 |
0.415 |
|
2019 |
Austad SN, Wood MA, Villeda SA, Voss JL, Sahay A, Albert M. Innovative approaches in cognitive aging. Neurobiology of Aging. PMID 31277894 DOI: 10.1016/J.Neurobiolaging.2019.04.013 |
0.356 |
|
2019 |
Soldan A, Moghekar A, Walker KA, Pettigrew C, Hou X, Lu H, Miller MI, Alfini A, Albert M, Xu D, Xiao MF, Worley P. Resting-State Functional Connectivity Is Associated With Cerebrospinal Fluid Levels of the Synaptic Protein NPTX2 in Non-demented Older Adults. Frontiers in Aging Neuroscience. 11: 132. PMID 31231205 DOI: 10.3389/Fnagi.2019.00132 |
0.401 |
|
2019 |
Rawlings AM, Sharrett AR, Albert MS, Coresh J, Windham BG, Power MC, Knopman DS, Walker K, Burgard S, Mosley TH, Gottesman RF, Selvin E. The Association of Late-Life Diabetes Status and Hyperglycemia With Incident Mild Cognitive Impairment and Dementia: The ARIC Study. Diabetes Care. 42: 1248-1254. PMID 31221696 DOI: 10.2337/Dc19-0120 |
0.358 |
|
2019 |
Lin Z, Sur S, Soldan A, Pettigrew C, Miller M, Oishi K, Bilgel M, Moghekar A, Pillai JJ, Albert M, Lu H. Brain Oxygen Extraction by Using MRI in Older Individuals: Relationship to Apolipoprotein E Genotype and Amyloid Burden. Radiology. 182726. PMID 31012816 DOI: 10.1148/Radiol.2019182726 |
0.436 |
|
2019 |
Younes L, Albert M, Moghekar A, Soldan A, Pettigrew C, Miller MI. Identifying Changepoints in Biomarkers During the Preclinical Phase of Alzheimer's Disease. Frontiers in Aging Neuroscience. 11: 74. PMID 31001108 DOI: 10.3389/Fnagi.2019.00074 |
0.446 |
|
2019 |
Wu D, Albert M, Soldan A, Pettigrew C, Oishi K, Tomogane Y, Ye C, Ma T, Miller MI, Mori S. Multi-atlas based detection and localization (MADL) for location-dependent quantification of white matter hyperintensities. Neuroimage. Clinical. 22: 101772. PMID 30927606 DOI: 10.1016/J.Nicl.2019.101772 |
0.364 |
|
2019 |
Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A, Bellenguez C, Frizatti A, Chouraki V, Martin ER, Sleegers K, ... ... Albert MS, et al. Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nature Genetics. 51: 414-430. PMID 30820047 DOI: 10.1038/s41588-019-0358-2 |
0.462 |
|
2019 |
Sabir MS, Blauwendraat C, Ahmed S, Serrano GE, Beach TG, Perkins M, Rice AC, Masliah E, Morris CM, Pihlstrom L, Pantelyat A, Resnick SM, Cookson MR, Hernandez DG, Albert M, et al. Assessment of APOE in atypical parkinsonism syndromes. Neurobiology of Disease. PMID 30798004 DOI: 10.1016/J.Nbd.2019.02.016 |
0.378 |
|
2019 |
Hua J, Lee S, Blair NIS, Wyss M, van Bergen JMG, Schreiner SJ, Kagerer SM, Leh SE, Gietl AF, Treyer V, Buck A, Nitsch RM, Pruessmann KP, Lu H, Van Zijl PCM, ... Albert M, et al. Increased cerebral blood volume in small arterial vessels is a correlate of amyloid-β-related cognitive decline. Neurobiology of Aging. 76: 181-193. PMID 30738323 DOI: 10.1016/J.Neurobiolaging.2019.01.001 |
0.438 |
|
2019 |
Swenor BK, Wang J, Varadaraj V, Rosano C, Yaffe K, Albert M, Simonsick EM. Corrigendum: Vision Impairment and Cognitive Outcomes in Older Adults: The Health ABC Study. Journals of Gerontology Series a-Biological Sciences and Medical Sciences. 74: 1484-1484. PMID 30649211 DOI: 10.1093/Gerona/Gly285 |
0.325 |
|
2019 |
Koychev I, Vaci N, Bilgel M, Muniz GT, Gallacher J, Resnick S, Albert M. 31 Prediction of emerging amyloid and tau pathology in cognitively healthy individuals: a longitudinal CSF study Journal of Neurology, Neurosurgery, and Psychiatry. 90. DOI: 10.1136/Jnnp-2019-Bnpa.31 |
0.451 |
|
2019 |
Sur S, Lin Z, Li Y, Yasar S, Rosenberg PB, Moghekar A, Wang Z, Hazel K, Pottanat G, Taneja K, Xu C, Van Zijl P, Pillai J, Liu P, Albert MS, et al. P1-363: CEREBRAL SMALL VESSEL REACTIVITY IS ASSOCIATED WITH COGNITIVE PERFORMANCE INDEPENDENT OF ALZHEIMER PATHOLOGY IN ELDERLY INDIVIDUALS Alzheimer's & Dementia. 15: P391-P392. DOI: 10.1016/J.Jalz.2019.06.918 |
0.428 |
|
2019 |
Pettigrew C, Soldan A, Wang J, Wang M, Gottesman RF, Moghekar A, Albert MS. O3-09-05: VASCULAR RISK FACTORS AND CSF AD BIOMARKERS ARE INDEPENDENTLY ASSOCIATED WITH COGNITIVE DECLINE Alzheimer's & Dementia. 15: P906-P907. DOI: 10.1016/J.Jalz.2019.06.4676 |
0.395 |
|
2019 |
Habes M, Pomponio R, Shou H, Doshi J, Sotiras A, Erus G, Launer LJ, Mamourian E, Bilgel M, Yaffe K, Srinivasan D, Espeland MA, Nasrallah IM, Rowe CC, Voelzke H, ... ... Albert MS, et al. IC-P-108: WHITE MATTER HYPERINTENSITIES IN RELATION TO PATTERNS OF ACCELERATED BRAIN AGING, AD-LIKE ATROPHY AND AMYLOID BURDEN: RESULTS FROM THE ISTAGING CONSORTIUM ON MACHINE LEARNING AND LARGE-SCALE IMAGING ANALYTICS Alzheimer's & Dementia. 15: P92-P93. DOI: 10.1016/J.Jalz.2019.06.4222 |
0.335 |
|
2019 |
Soldan A, Pettigrew C, Zhu Y, Wang M, Gottesman RF, Albert MS. P4-447: COGNITIVE RESERVE MITIGATES THE IMPACT OF HYPERTENSION ON COGNITIVE TRAJECTORIES Alzheimer's & Dementia. 15: P1475-P1475. DOI: 10.1016/J.Jalz.2019.06.4119 |
0.355 |
|
2019 |
Gross AL, Walker KA, Moghekar A, Pettigrew C, Soldan A, Albert MS, Walston J. P2-550: Plasma Measures Of Inflammation Associated With Clinical Progression And Cognitive Decline During Preclinical Ad Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.2958 |
0.414 |
|
2018 |
Sathe G, Na CH, Renuse S, Madugundu AK, Albert M, Moghekar A, Pandey A. Quantitative proteomic profiling of cerebrospinal fluid to identify candidate biomarkers for Alzheimer's disease. Proteomics. Clinical Applications. e1800105. PMID 30578620 DOI: 10.1002/Prca.201800105 |
0.391 |
|
2018 |
Kulason S, Tward DJ, Brown T, Sicat CS, Liu CF, Ratnanather JT, Younes L, Bakker A, Gallagher M, Albert M, Miller MI. Cortical thickness atrophy in the transentorhinal cortex in mild cognitive impairment. Neuroimage. Clinical. PMID 30552075 DOI: 10.1016/J.Nicl.2018.101617 |
0.394 |
|
2018 |
Bell WR, An Y, Kageyama Y, English C, Rudow GL, Pletnikova O, Thambisetty M, O'Brien R, Moghekar AR, Albert MS, Rabins PV, Resnick SM, Troncoso JC. Neuropathologic, genetic, and longitudinal cognitive profiles in primary age-related tauopathy and Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30465754 DOI: 10.1016/J.Jalz.2018.07.215 |
0.493 |
|
2018 |
Deal JA, Sharrett AR, Albert M, Bandeen-Roche K, Burgard S, Thomas SD, Gottesman RF, Knopman D, Mosley T, Klein B, Klein R. Retinal signs and risk of incident dementia in the Atherosclerosis Risk in Communities study. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30439332 DOI: 10.1016/J.Jalz.2018.10.002 |
0.302 |
|
2018 |
Cabeza R, Albert M, Belleville S, Craik FIM, Duarte A, Grady CL, Lindenberger U, Nyberg L, Park DC, Reuter-Lorenz PA, Rugg MD, Steffener J, Rajah MN. Author Correction: Maintenance, reserve and compensation: the cognitive neuroscience of healthy ageing. Nature Reviews. Neuroscience. PMID 30405175 DOI: 10.1038/S41583-018-0086-0 |
0.369 |
|
2018 |
Pettigrew C, Shao Y, Zhu Y, Grega M, Brichko R, Wang MC, Carlson MC, Albert M, Soldan A. Self-reported Lifestyle Activities in Relation to Longitudinal Cognitive Trajectories. Alzheimer Disease and Associated Disorders. PMID 30376509 DOI: 10.1097/Wad.0000000000000281 |
0.367 |
|
2018 |
Deal JA, Goman AM, Albert MS, Arnold ML, Burgard S, Chisolm T, Couper D, Glynn NW, Gmelin T, Hayden KM, Mosley T, Pankow JS, Reed N, Sanchez VA, Richey Sharrett A, et al. Hearing treatment for reducing cognitive decline: Design and methods of the Aging and Cognitive Health Evaluation in Elders randomized controlled trial. Alzheimer's & Dementia (New York, N. Y.). 4: 499-507. PMID 30364572 DOI: 10.1016/J.Trci.2018.08.007 |
0.379 |
|
2018 |
Swenor BK, Wang J, Varadaraj V, Rosano C, Yaffe K, Albert M, Simonsick EM. Vision Impairment and Cognitive Outcomes in Older Adults: The Health ABC Study. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. PMID 30358809 DOI: 10.1093/Gerona/Gly244 |
0.347 |
|
2018 |
Cabeza R, Albert M, Belleville S, Craik FIM, Duarte A, Grady CL, Lindenberger U, Nyberg L, Park DC, Reuter-Lorenz PA, Rugg MD, Steffener J, Rajah MN. Maintenance, reserve and compensation: the cognitive neuroscience of healthy ageing. Nature Reviews. Neuroscience. PMID 30305711 DOI: 10.1038/S41583-018-0068-2 |
0.393 |
|
2018 |
Pletnikova O, Kageyama Y, Rudow G, LaClair KD, Albert M, Crain BJ, Tian J, Fowler D, Troncoso JC. The spectrum of preclinical Alzheimer's disease pathology and its modulation by ApoE genotype. Neurobiology of Aging. 71: 72-80. PMID 30099348 DOI: 10.1016/J.Neurobiolaging.2018.07.007 |
0.384 |
|
2018 |
Hohman TJ, Dumitrescu L, Barnes LL, Thambisetty M, Beecham G, Kunkle B, Gifford KA, Bush WS, Chibnik LB, Mukherjee S, De Jager PL, Kukull W, Crane PK, Resnick SM, Keene CD, ... ... Albert M, et al. Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau. Jama Neurology. PMID 29801024 DOI: 10.1001/Jamaneurol.2018.0821 |
0.369 |
|
2018 |
Wolk DA, Sadowsky C, Safirstein B, Rinne JO, Duara R, Perry R, Agronin M, Gamez J, Shi J, Ivanoiu A, Minthon L, Walker Z, Hasselbalch S, Holmes C, Sabbagh M, ... Albert M, et al. Use of Flutemetamol F 18-Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment. Jama Neurology. PMID 29799984 DOI: 10.1001/Jamaneurol.2018.0894 |
0.442 |
|
2018 |
Knopman DS, Gottesman RF, Sharrett AR, Tapia AL, DavisThomas S, Windham BG, Coker L, Schneider ALC, Alonso A, Coresh J, Albert MS, Mosley TH. Midlife vascular risk factors and midlife cognitive status in relation to prevalence of mild cognitive impairment and dementia in later life: The Atherosclerosis Risk in Communities Study. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29763593 DOI: 10.1016/J.Jalz.2018.03.011 |
0.396 |
|
2018 |
Deal JA, Sharrett AR, Rawlings AM, Gottesman RF, Bandeen-Roche K, Albert M, Knopman D, Selvin E, Wasserman BA, Klein B, Klein R. Retinal signs and 20-year cognitive decline in the Atherosclerosis Risk in Communities Study. Neurology. PMID 29490915 DOI: 10.1212/Wnl.0000000000005205 |
0.342 |
|
2018 |
Cholerton B, Johnson CO, Fish B, Quinn JF, Chung KA, Peterson-Hiller AL, Rosenthal LS, Dawson TM, Albert MS, Hu SC, Mata IF, Leverenz JB, Poston KL, Montine TJ, Zabetian CP, et al. Sex differences in progression to mild cognitive impairment and dementia in Parkinson's disease. Parkinsonism & Related Disorders. PMID 29478836 DOI: 10.1016/J.Parkreldis.2018.02.007 |
0.419 |
|
2018 |
Soldan A, Pettigrew C, Albert M. Evaluating Cognitive Reserve Through the Prism of Preclinical Alzheimer Disease. The Psychiatric Clinics of North America. 41: 65-77. PMID 29412849 DOI: 10.1016/J.Psc.2017.10.006 |
0.453 |
|
2018 |
Klinger RY, James OG, Borges-Neto S, Bisanar T, Li YJ, Qi W, Berger M, Terrando N, Newman MF, Doraiswamy PM, Mathew JP, Weiner MW, Aisen P, Weiner M, Aisen P, ... ... Albert M, ... ... Albert M, et al. 18F-florbetapir Positron Emission Tomography-determined Cerebral β-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery. Anesthesiology. PMID 29389750 DOI: 10.1097/Aln.0000000000002103 |
0.681 |
|
2018 |
Albert M, Zhu Y, Moghekar A, Mori S, Miller MI, Soldan A, Pettigrew C, Selnes O, Li S, Wang MC. Predicting progression from normal cognition to mild cognitive impairment for individuals at 5 years. Brain : a Journal of Neurology. PMID 29365053 DOI: 10.1093/Brain/Awx365 |
0.347 |
|
2018 |
Kulason S, Tward DJ, Sicat CS, Bakker A, Gallagher M, Albert MS, Miller M. Ic-P-098: Cortical Thickness Atrophy In The Transentorhinal Cortex In Mild Cognitive Impairment Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2162 |
0.357 |
|
2018 |
Dumitrescu L, Deming Y, Lu Q, Beecham GW, Kunkle BW, Del-Aguila JL, Fernandez MV, Budde JP, Fagan AM, Jager PLD, Albert MS, Moghekar A, Riemenschneider M, Petersen RC, Barnes LL, et al. P1-139: The Contribution Of Sex-Specific Associations In Genetic Studies Of Alzheimer'S Disease Pathology Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.142 |
0.372 |
|
2018 |
Chan CK, Soldan A, Pettigrew C, Wang MC, Wang J, Albert M, Rosenberg PB. Depression Severity in Relation to Clinical Symptom Onset in Mild Cognitive Impairment The American Journal of Geriatric Psychiatry. 26: S140-S141. DOI: 10.1016/J.Jagp.2018.01.171 |
0.336 |
|
2017 |
Deal JA, Albert MS, Arnold M, Bangdiwala SI, Chisolm T, Davis S, Eddins A, Glynn NW, Goman AM, Minotti M, Mosley T, Rebok GW, Reed N, Rodgers E, Sanchez V, et al. A randomized feasibility pilot trial of hearing treatment for reducing cognitive decline: Results from the Aging and Cognitive Health Evaluation in Elders Pilot Study. Alzheimer's & Dementia (New York, N. Y.). 3: 410-415. PMID 29067347 DOI: 10.1016/J.Trci.2017.06.003 |
0.388 |
|
2017 |
Graff-Radford J, Simino J, Kantarci K, Mosley TH, Griswold ME, Windham BG, Sharrett AR, Albert MS, Gottesman RF, Jack CR, Vemuri P, Knopman DS. Neuroimaging Correlates of Cerebral Microbleeds: The ARIC Study (Atherosclerosis Risk in Communities). Stroke. PMID 29018129 DOI: 10.1161/Strokeaha.117.018336 |
0.347 |
|
2017 |
Tward DJ, Sicat CS, Brown T, Bakker A, Gallagher M, Albert M, Miller M. Entorhinal and transentorhinal atrophy in mild cognitive impairment using longitudinal diffeomorphometry. Alzheimer's & Dementia (Amsterdam, Netherlands). 9: 41-50. PMID 28971142 DOI: 10.1016/J.Dadm.2017.07.005 |
0.435 |
|
2017 |
Soldan A, Pettigrew C, Cai Q, Wang J, Wang MC, Moghekar A, Miller MI, Albert M. Cognitive reserve and long-term change in cognition in aging and preclinical Alzheimer's disease. Neurobiology of Aging. 60: 164-172. PMID 28968586 DOI: 10.1016/J.Neurobiolaging.2017.09.002 |
0.459 |
|
2017 |
Gottesman RF, Albert MS, Alonso A, Coker LH, Coresh J, Davis SM, Deal JA, McKhann GM, Mosley TH, Sharrett AR, Schneider ALC, Windham BG, Wruck LM, Knopman DS. Associations Between Midlife Vascular Risk Factors and 25-Year Incident Dementia in the Atherosclerosis Risk in Communities (ARIC) Cohort. Jama Neurology. PMID 28783817 DOI: 10.1001/Jamaneurol.2017.1658 |
0.341 |
|
2017 |
Sims R, van der Lee SJ, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J, Kunkle BW, Boland A, Raybould R, Bis JC, Martin ER, Grenier-Boley B, Heilmann-Heimbach S, Chouraki V, Kuzma AB, ... ... Albert MS, et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nature Genetics. PMID 28714976 DOI: 10.1038/Ng.3916 |
0.517 |
|
2017 |
Gross AL, Hassenstab JJ, Johnson SC, Clark LR, Resnick SM, Kitner-Triolo M, Masters CL, Maruff P, Morris JC, Soldan A, Pettigrew C, Albert MS. A classification algorithm for predicting progression from normal cognition to mild cognitive impairment across five cohorts: The preclinical AD consortium. Alzheimer's & Dementia (Amsterdam, Netherlands). 8: 147-155. PMID 28653035 DOI: 10.1016/J.Dadm.2017.05.003 |
0.458 |
|
2017 |
Tzuang M, Owusu JT, Spira AP, Albert MS, Rebok GW. Cognitive Training for Ethnic Minority Older Adults in the United States: A Review. The Gerontologist. PMID 28575230 DOI: 10.1093/Geront/Gnw260 |
0.333 |
|
2017 |
Wennberg AMV, Hagen CE, Gottesman RF, Zipunnikov V, Kaufmann CN, Albert MS, Rebok GW, Kasper JD, Spira AP. Longitudinal association between diabetes and cognitive decline: The National Health and Aging Trends Study. Archives of Gerontology and Geriatrics. 72: 39-44. PMID 28544945 DOI: 10.1016/J.Archger.2017.05.005 |
0.377 |
|
2017 |
Sacktor N, Soldan A, Grega M, Farrington L, Cai Q, Wang MC, Gottesman RF, Turner RS, Albert M. The BIOCARD Index: A Summary Measure to Predict Onset of Mild Cognitive Impairment. Alzheimer Disease and Associated Disorders. PMID 28394770 DOI: 10.1097/Wad.0000000000000194 |
0.406 |
|
2017 |
Thaker AA, Weinberg BD, Dillon WP, Hess CP, Cabral HJ, Fleischman DA, Leurgans SE, Bennett DA, Hyman BT, Albert MS, Killiany RJ, Fischl B, Dale AM, Desikan RS. Entorhinal Cortex: Antemortem Cortical Thickness and Postmortem Neurofibrillary Tangles and Amyloid Pathology. Ajnr. American Journal of Neuroradiology. PMID 28279988 DOI: 10.3174/Ajnr.A5133 |
0.316 |
|
2017 |
Couser E, Albert M, Pettigrew C, Soldan A. COGNITIVE MEASURE MAY IDENTIFY ATROPHY IN BRAIN REGIONS ASSOCIATED WITH POSTERIOR CORTICAL ATROPHY Innovation in Aging. 1: 587-587. DOI: 10.1093/Geroni/Igx004.2060 |
0.373 |
|
2017 |
Deming Y, Kapoor M, Li Z, Harari O, Black K, Del-Aguila JL, Carrell D, Cai Y, Fernandez MV, Budde JP, Ma S, Saef B, Howells B, Huang K, Bertelsen S, ... ... Albert MS, et al. CEREBROSPINAL FLUID ENDOPHENOTYPES PROVIDE INSIGHT INTO BIOLOGY UNDERLYING ALZHEIMER'S DISEASE Alzheimer's & Dementia. 13: P218-P219. DOI: 10.1016/J.Jalz.2017.07.096 |
0.358 |
|
2016 |
McAdams-DeMarco MA, Bae S, Chu N, Gross AL, Brown CH, Oh E, Rosenberg P, Neufeld KJ, Varadhan R, Albert M, Walston J, Segev DL. Dementia and Alzheimer's Disease among Older Kidney Transplant Recipients. Journal of the American Society of Nephrology : Jasn. PMID 27979990 DOI: 10.1681/ASN.2016080816 |
0.389 |
|
2016 |
Chapuis J, Flaig A, Grenier-Boley B, Eysert F, Pottiez V, Deloison G, Vandeputte A, Ayral AM, Mendes T, Desai S, Goate AM, Kauwe JS, Leroux F, Herledan A, Demiautte F, ... ... Albert M, et al. Genome-wide, high-content siRNA screening identifies the Alzheimer's genetic risk factor FERMT2 as a major modulator of APP metabolism. Acta Neuropathologica. PMID 27933404 DOI: 10.1007/S00401-016-1652-Z |
0.342 |
|
2016 |
Soldan A, Pettigrew C, Moghekar A, Albert M. Computerized Cognitive Tests Are Associated with Biomarkers of Alzheimer's Disease in Cognitively Normal Individuals 10 Years Prior. Journal of the International Neuropsychological Society : Jins. 22: 968-977. PMID 27903332 DOI: 10.1017/S1355617716000722 |
0.48 |
|
2016 |
Gross AL, Mungas DM, Leoutsakos JS, Albert MS, Jones RN. Alzheimer's disease severity, objectively determined and measured. Alzheimer's & Dementia (Amsterdam, Netherlands). 4: 159-168. PMID 27830173 DOI: 10.1016/J.Dadm.2016.08.005 |
0.418 |
|
2016 |
Davis MY, Johnson CO, Leverenz JB, Weintraub D, Trojanowski JQ, Chen-Plotkin A, Van Deerlin VM, Quinn JF, Chung KA, Peterson-Hiller AL, Rosenthal LS, Dawson TM, Albert MS, Goldman JG, Stebbins GT, et al. Association of GBA Mutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease. Jama Neurology. PMID 27571329 DOI: 10.1001/Jamaneurol.2016.2245 |
0.323 |
|
2016 |
Pettigrew C, Soldan A, Zhu Y, Wang MC, Brown T, Miller M, Albert M. Cognitive reserve and cortical thickness in preclinical Alzheimer's disease. Brain Imaging and Behavior. PMID 27544202 DOI: 10.1007/S11682-016-9581-Y |
0.44 |
|
2016 |
Pettigrew C, Soldan A, Zhu Y, Wang MC, Moghekar A, Brown T, Miller M, Albert M. Cortical thickness in relation to clinical symptom onset in preclinical AD. Neuroimage. Clinical. 12: 116-22. PMID 27408796 DOI: 10.1016/J.Nicl.2016.06.010 |
0.368 |
|
2016 |
Geiger JT, Ding J, Crain B, Pletnikova O, Letson C, Dawson TM, Rosenthal LS, Pantelyat A, Gibbs JR, Albert MS, Hernandez DG, Hillis AE, Stone DJ, Singleton AB, et al. Next-generation sequencing reveals substantial genetic contribution to dementia with Lewy bodies. Neurobiology of Disease. PMID 27312774 DOI: 10.1016/J.Nbd.2016.06.004 |
0.313 |
|
2016 |
Geiger JT, Arthur KC, Dawson TM, Rosenthal LS, Pantelyat A, Albert M, Hillis AE, Crain B, Pletnikova O, Troncoso JC, Scholz SW. C9orf72 Hexanucleotide Repeat Analysis in Cases with Pathologically Confirmed Dementia with Lewy Bodies. Neuro-Degenerative Diseases. 16: 370-372. PMID 27241037 DOI: 10.1159/000445872 |
0.35 |
|
2016 |
Wennberg AM, Spira AP, Pettigrew C, Soldan A, Zipunnikov V, Rebok GW, Roses AD, Lutz MW, Miller MM, Thambisetty M, Albert MS. Blood glucose levels and cortical thinning in cognitively normal, middle-aged adults. Journal of the Neurological Sciences. 365: 89-95. PMID 27206882 DOI: 10.1016/J.Jns.2016.04.017 |
0.395 |
|
2016 |
Soldan A, Pettigrew C, Cai Q, Wang MC, Moghekar AR, O'Brien RJ, Selnes OA, Albert MS. Hypothetical Preclinical Alzheimer Disease Groups and Longitudinal Cognitive Change. Jama Neurology. PMID 27064267 DOI: 10.1001/Jamaneurol.2016.0194 |
0.445 |
|
2016 |
Knopman DS, Gottesman RF, Sharrett AR, Wruck LM, Windham BG, Coker L, Schneider AL, Hengrui S, Alonso A, Coresh J, Albert MS, Mosley TH. Mild Cognitive Impairment and Dementia Prevalence: The Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS). Alzheimer's & Dementia (Amsterdam, Netherlands). 2: 1-11. PMID 26949733 DOI: 10.1016/J.Dadm.2015.12.002 |
0.399 |
|
2016 |
Thomas RG, Albert M, Petersen RC, Aisen PS. Longitudinal decline in mild-to-moderate Alzheimer's disease: Analyses of placebo data from clinical trials. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 26917500 DOI: 10.1016/J.Jalz.2016.01.002 |
0.465 |
|
2016 |
McCutcheon ST, Han D, Troncoso J, Koliatsos VE, Albert M, Lyketsos CG, Leoutsakos JS. Clinicopathological correlates of depression in early Alzheimer's disease in the NACC. International Journal of Geriatric Psychiatry. PMID 26876501 DOI: 10.1002/Gps.4435 |
0.424 |
|
2016 |
Deming Y, Harari O, Black K, Carrell D, Cai Y, Del-Aguila JL, Fernandez V, Budde J, Ma S, Saef B, Bertelsen S, Kauwe J, Fagan AM, Holtzman DM, Morris JC, ... ... Albert MS, et al. Cerebrospinal Fluid Levels Of Amyloid Beta And Tau As Endophenotypes Reveal Novel Variants Potentially Informative For Alzheimer'S Disease Alzheimers & Dementia. 12: 252. DOI: 10.1016/J.Jalz.2016.06.452 |
0.336 |
|
2016 |
Lin FR, Albert MS, Alonso A, Bangdiwala S, Chisolm T, Coker L, Deal J, Davis S, Minotti M, Mosley TH, Rebok G, Sharrett R, Coresh J. P3-033: Results from the Achieve-P Study: A Pilot Study for a Randomized Controlled Trial to Determine if Hearing Loss Treatment Can Reduce the Risk of Cognitive Decline in Older Adults Alzheimer's & Dementia. 12: P829-P830. DOI: 10.1016/J.Jalz.2016.06.1690 |
0.328 |
|
2016 |
Varma VR, Varma S, An Y, Beri A, Dammer EB, Seyfried NT, Moghekar A, Wilson M, Lah JJ, O’Brien R, Levey AI, Troncoso JC, Albert MS, Thambisetty M. The Acute Phase Protein Alpha-2-Macroglobulin Predicts Risk Of Incident Alzheimer'S Disease And Modulates Tau Pathology Through The Rcan1-Calcineurin Pathway Alzheimers & Dementia. 12: 745. DOI: 10.1016/J.Jalz.2016.06.1554 |
0.317 |
|
2015 |
Gauthier S, Albert M, Fox N, Goedert M, Kivipelto M, Mestre-Ferrandiz J, Middleton LT. "Why therapy development for dementia has failed in the last two decades?" Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 26710325 DOI: 10.1016/J.Jalz.2015.12.003 |
0.3 |
|
2015 |
Gross AL, Power MC, Albert MS, Deal JA, Gottesman RF, Griswold M, Wruck LM, Mosley TH, Coresh J, Sharrett AR, Bandeen-Roche K. Application of Latent Variable Methods to the Study of Cognitive Decline When Tests Change over Time. Epidemiology (Cambridge, Mass.). 26: 878-87. PMID 26414855 DOI: 10.1097/Ede.0000000000000379 |
0.384 |
|
2015 |
Pettigrew C, Soldan A, Moghekar A, Wang MC, Gross AL, O'Brien R, Albert M. Relationship between Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Cognition in Cognitively Normal Older Adults. Neuropsychologia. PMID 26394023 DOI: 10.1016/J.Neuropsychologia.2015.09.024 |
0.37 |
|
2015 |
Mata IF, Leverenz JB, Weintraub D, Trojanowski JQ, Chen-Plotkin A, Van Deerlin VM, Ritz B, Rausch R, Factor SA, Wood-Siverio C, Quinn JF, Chung KA, Peterson-Hiller AL, Goldman JG, Stebbins GT, ... ... Albert MS, et al. GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26296077 DOI: 10.1002/Mds.26359 |
0.354 |
|
2015 |
Miller MI, Ratnanather JT, Tward DJ, Brown T, Lee DS, Ketcha M, Mori K, Wang MC, Mori S, Albert MS, Younes L. Network Neurodegeneration in Alzheimer's Disease via MRI Based Shape Diffeomorphometry and High-Field Atlasing. Frontiers in Bioengineering and Biotechnology. 3: 54. PMID 26284236 DOI: 10.3389/Fbioe.2015.00054 |
0.37 |
|
2015 |
Toledo JB, Zetterberg H, van Harten AC, Glodzik L, Martinez-Lage P, Bocchio-Chiavetto L, Rami L, Hansson O, Sperling R, Engelborghs S, Osorio RS, Vanderstichele H, Vandijck M, Hampel H, Teipl S, ... ... Albert M, et al. Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects. Brain : a Journal of Neurology. 138: 2701-15. PMID 26220940 DOI: 10.1093/Brain/Awv199 |
0.509 |
|
2015 |
Resnick SM, Bilgel M, Moghekar A, An Y, Cai Q, Wang MC, Thambisetty M, Prince JL, Zhou Y, Soldan A, Wong DF, O'Brien RJ, Ferrucci L, Albert MS. Changes in Aβ biomarkers and associations with APOE genotype in 2 longitudinal cohorts. Neurobiology of Aging. 36: 2333-9. PMID 26004017 DOI: 10.1016/J.Neurobiolaging.2015.04.001 |
0.453 |
|
2015 |
Deal JA, Sharrett AR, Albert MS, Coresh J, Mosley TH, Knopman D, Wruck LM, Lin FR. Hearing impairment and cognitive decline: a pilot study conducted within the atherosclerosis risk in communities neurocognitive study. American Journal of Epidemiology. 181: 680-90. PMID 25841870 DOI: 10.1093/Aje/Kwu333 |
0.397 |
|
2015 |
Carlson MC, Kuo JH, Chuang YF, Varma VR, Harris G, Albert MS, Erickson KI, Kramer AF, Parisi JM, Xue QL, Tan EJ, Tanner EK, Gross AL, Seeman TE, Gruenewald TL, et al. Impact of the Baltimore Experience Corps Trial on cortical and hippocampal volumes. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 25835516 DOI: 10.1016/J.Jalz.2014.12.005 |
0.559 |
|
2015 |
Srivatsal S, Cholerton B, Leverenz JB, Wszolek ZK, Uitti RJ, Dickson DW, Weintraub D, Trojanowski JQ, Van Deerlin VM, Quinn JF, Chung KA, Peterson AL, Factor SA, Wood-Siverio C, Goldman JG, ... ... Albert MS, et al. Cognitive profile of LRRK2-related Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 728-33. PMID 25650144 DOI: 10.1002/Mds.26161 |
0.327 |
|
2015 |
Knopman DS, Griswold ME, Lirette ST, Gottesman RF, Kantarci K, Sharrett AR, Jack CR, Graff-Radford J, Schneider AL, Windham BG, Coker LH, Albert MS, Mosley TH. Vascular imaging abnormalities and cognition: mediation by cortical volume in nondemented individuals: atherosclerosis risk in communities-neurocognitive study. Stroke; a Journal of Cerebral Circulation. 46: 433-40. PMID 25563642 DOI: 10.1161/Strokeaha.114.007847 |
0.353 |
|
2015 |
Wang LS, Naj AC, Graham RR, Crane PK, Kunkle BW, Cruchaga C, Murcia JD, Cannon-Albright L, Baldwin CT, Zetterberg H, Blennow K, Kukull WA, Faber KM, Schupf N, Norton MC, ... ... Albert MS, et al. Rarity of the Alzheimer disease-protective APP A673T variant in the United States. Jama Neurology. 72: 209-16. PMID 25531812 DOI: 10.1001/Jamaneurol.2014.2157 |
0.415 |
|
2015 |
Miller MI, Younes L, Ratnanather JT, Brown T, Trinh H, Lee DS, Tward D, Mahon PB, Mori S, Albert M. Amygdalar atrophy in symptomatic Alzheimer's disease based on diffeomorphometry: the BIOCARD cohort. Neurobiology of Aging. 36: S3-S10. PMID 25444602 DOI: 10.1016/J.Neurobiolaging.2014.06.032 |
0.428 |
|
2015 |
Nowrangi MA, Okonkwo O, Lyketsos C, Oishi K, Mori S, Albert M, Mielke MM. Atlas-based diffusion tensor imaging correlates of executive function. Journal of Alzheimer's Disease : Jad. 44: 585-98. PMID 25318544 DOI: 10.3233/Jad-141937 |
0.416 |
|
2015 |
Toledo JB, Zetterberg H, Van Harten AC, Glodzik L, Martinez-Lage P, Bocchio-Chiavetto L, Rami L, Hansson O, Sperling R, Engelborghs S, Osorio RS, Vanderstichele H, Vandijck M, Hampel H, Teipl S, ... ... Albert M, et al. Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects Brain. 138: 2701-2715. DOI: 10.1093/brain/awv199 |
0.439 |
|
2015 |
Albert MS, Soldan A, Selnes O, Miller M, Ratnanather T, Mori S, Moghekar A, O'Brien R, Scherer R, Li S, Wang M. F1-03-02: Using combinations of variables to identify individuals with preclinical ad Alzheimer's & Dementia. 11: P118-P118. DOI: 10.1016/J.Jalz.2015.07.015 |
0.301 |
|
2015 |
Breitner JCS, Albert MS, Poirier J, Etienne PE. Potential of ad biomarkers to reveal the presymptomatic disease process and the effects of treatments that may retard it Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.07.014 |
0.358 |
|
2015 |
Lutz MW, Soldan A, Selnes O, Roses AD, Saunders AM, Burns DK, Albert MS. P3-018: Tomm40/ApoE variation and age of onset of mild cognitive impairment and dementia in a prospective, longitudinal study Alzheimer's & Dementia. 11: P626-P627. DOI: 10.1016/J.Jalz.2015.06.884 |
0.445 |
|
2015 |
Soldan A, Pettigrew CA, Cai Q, Wang M, Moghekar A, Miller M, Ratnanather T, Mori S, Albert MS. P1-113: Relationship of CSF tau and ß-amyloid to hippocampal atrophy rates Alzheimer's & Dementia. 11: P383-P383. DOI: 10.1016/J.Jalz.2015.06.311 |
0.312 |
|
2015 |
Gross AL, Mungas D, Albert MS, Leoutsakos JS, Jones RN. Alzheimer disease severity objectively determined and measured Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.06.1849 |
0.346 |
|
2015 |
Lin F, Albert MS, Alonso A, Chisolm T, Coker L, Crowley P, Deal J, Eddins A, Minotti M, Mosley T, Rebok G, Sharrett R, Wruck L, Coresh J. P3-312: Development of the achieve healthy aging study: A randomized controlled trial to determine if hearing loss treatment can reduce the risk of cognitive decline and dementia in older adults Alzheimer's & Dementia. 11: P756-P757. DOI: 10.1016/J.Jalz.2015.06.1686 |
0.378 |
|
2015 |
Wennberg AM, Zipunnikov V, Kaufmann CN, Gottesman RF, Albert M, Rebok GW, Kasper JD, Spira AP. Longitudinal Association Between Diabetes and Cognitive Decline in a Nationally Representative Sample: The National Health and Aging Trends Study The American Journal of Geriatric Psychiatry. 23: S93-S94. DOI: 10.1016/J.Jagp.2014.12.095 |
0.344 |
|
2014 |
Rawlings AM, Sharrett AR, Schneider AL, Coresh J, Albert M, Couper D, Griswold M, Gottesman RF, Wagenknecht LE, Windham BG, Selvin E. Diabetes in midlife and cognitive change over 20 years: a cohort study. Annals of Internal Medicine. 161: 785-93. PMID 25437406 DOI: 10.7326/M14-0737 |
0.317 |
|
2014 |
Fargo KN, Aisen P, Albert M, Au R, Corrada MM, DeKosky S, Drachman D, Fillit H, Gitlin L, Haas M, Herrup K, Kawas C, Khachaturian AS, Khachaturian ZS, et al. 2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: S430-52. PMID 25341459 DOI: 10.1016/J.Jalz.2014.08.103 |
0.612 |
|
2014 |
Naj AC, Jun G, Reitz C, Kunkle BW, Perry W, Park YS, Beecham GW, Rajbhandary RA, Hamilton-Nelson KL, Wang LS, Kauwe JS, Huentelman MJ, Myers AJ, Bird TD, Boeve BF, ... ... Albert MS, et al. Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. Jama Neurology. 71: 1394-404. PMID 25199842 DOI: 10.1001/Jamaneurol.2014.1491 |
0.524 |
|
2014 |
Hughes TB, Black BS, Albert M, Gitlin LN, Johnson DM, Lyketsos CG, Samus QM. Correlates of objective and subjective measures of caregiver burden among dementia caregivers: influence of unmet patient and caregiver dementia-related care needs. International Psychogeriatrics / Ipa. 26: 1875-83. PMID 25104063 DOI: 10.1017/S1041610214001240 |
0.305 |
|
2014 |
Younes L, Albert M, Miller MI. Inferring changepoint times of medial temporal lobe morphometric change in preclinical Alzheimer's disease. Neuroimage. Clinical. 5: 178-87. PMID 25101236 DOI: 10.1016/J.Nicl.2014.04.009 |
0.307 |
|
2014 |
Gottesman RF, Schneider AL, Albert M, Alonso A, Bandeen-Roche K, Coker L, Coresh J, Knopman D, Power MC, Rawlings A, Sharrett AR, Wruck LM, Mosley TH. Midlife hypertension and 20-year cognitive change: the atherosclerosis risk in communities neurocognitive study. Jama Neurology. 71: 1218-27. PMID 25090106 DOI: 10.1001/Jamaneurol.2014.1646 |
0.39 |
|
2014 |
Wennberg AM, Gottesman RF, Kaufmann CN, Albert MS, Chen-Edinboro LP, Rebok GW, Kasper JD, Spira AP. Diabetes and cognitive outcomes in a nationally representative sample: the National Health and Aging Trends Study. International Psychogeriatrics / Ipa. 26: 1729-35. PMID 25075535 DOI: 10.1017/S1041610214001380 |
0.36 |
|
2014 |
Lin FR, Albert M. Hearing loss and dementia - who is listening? Aging & Mental Health. 18: 671-3. PMID 24875093 DOI: 10.1080/13607863.2014.915924 |
0.387 |
|
2014 |
Cosentino S, Zahodne LB, Brandt J, Blacker D, Albert M, Dubois B, Stern Y. Social cognition in Alzheimer's disease: a separate construct contributing to dependence. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 818-26. PMID 24656839 DOI: 10.1016/J.Jalz.2013.12.021 |
0.431 |
|
2014 |
Gottesman RF, Rawlings AM, Sharrett AR, Albert M, Alonso A, Bandeen-Roche K, Coker LH, Coresh J, Couper DJ, Griswold ME, Heiss G, Knopman DS, Patel MD, Penman AD, Power MC, et al. Impact of differential attrition on the association of education with cognitive change over 20 years of follow-up: the ARIC neurocognitive study. American Journal of Epidemiology. 179: 956-66. PMID 24627572 DOI: 10.1093/Aje/Kwu020 |
0.384 |
|
2014 |
Gu Y, Scarmeas N, Cosentino S, Brandt J, Albert M, Blacker D, Dubois B, Stern Y. Change in body mass index before and after Alzheimer's disease onset. Current Alzheimer Research. 11: 349-56. PMID 24251397 DOI: 10.2174/1567205010666131120110930 |
0.37 |
|
2014 |
Razlighi QR, Stallard E, Brandt J, Blacker D, Albert M, Scarmeas N, Kinosian B, Yashin AI, Stern Y. A new algorithm for predicting time to disease endpoints in Alzheimer's disease patients. Journal of Alzheimer's Disease : Jad. 38: 661-8. PMID 24064468 DOI: 10.3233/Jad-131142 |
0.339 |
|
2014 |
Zhang Y, Zhang J, Hsu J, Oishi K, Faria AV, Albert M, Miller MI, Mori S. Evaluation of group-specific, whole-brain atlas generation using Volume-based Template Estimation (VTE): application to normal and Alzheimer's populations. Neuroimage. 84: 406-19. PMID 24051356 DOI: 10.1016/J.Neuroimage.2013.09.011 |
0.301 |
|
2013 |
Li S, Okonkwo O, Albert M, Wang MC. Variation in Variables that Predict Progression from MCI to AD Dementia over Duration of Follow-up. American Journal of Alzheimer's Disease (Columbia, Mo.). 2: 12-28. PMID 24524014 DOI: 10.7726/ajad.2013.1002 |
0.391 |
|
2013 |
Miller MI, Younes L, Ratnanather JT, Brown T, Trinh H, Postell E, Lee DS, Wang MC, Mori S, O'Brien R, Albert M. The diffeomorphometry of temporal lobe structures in preclinical Alzheimer's disease. Neuroimage. Clinical. 3: 352-60. PMID 24363990 DOI: 10.1016/J.Nicl.2013.09.001 |
0.38 |
|
2013 |
Moghekar A, Li S, Lu Y, Li M, Wang MC, Albert M, O'Brien R. CSF biomarker changes precede symptom onset of mild cognitive impairment. Neurology. 81: 1753-8. PMID 24132375 DOI: 10.1212/01.Wnl.0000435558.98447.17 |
0.431 |
|
2013 |
Soldan A, Pettigrew C, Li S, Wang MC, Moghekar A, Selnes OA, Albert M, O'Brien R. Relationship of cognitive reserve and cerebrospinal fluid biomarkers to the emergence of clinical symptoms in preclinical Alzheimer's disease. Neurobiology of Aging. 34: 2827-34. PMID 23916061 DOI: 10.1016/J.Neurobiolaging.2013.06.017 |
0.424 |
|
2013 |
Zhu CW, Livote EE, Scarmeas N, Albert M, Brandt J, Blacker D, Sano M, Stern Y. Long-term associations between cholinesterase inhibitors and memantine use and health outcomes among patients with Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 733-40. PMID 23332671 DOI: 10.1016/J.Jalz.2012.09.015 |
0.421 |
|
2013 |
Nowrangi MA, Lyketsos CG, Leoutsakos JM, Oishi K, Albert M, Mori S, Mielke MM. Longitudinal, region-specific course of diffusion tensor imaging measures in mild cognitive impairment and Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 519-28. PMID 23245561 DOI: 10.1016/J.Jalz.2012.05.2186 |
0.446 |
|
2013 |
Chuang Y, Varma V, Haris G, Albert M, Fried L, Rebok G, Xue Q, Carlson M. The association between cardiovascular risk and neurocognitive measures of executive function in at-risk, community-dwelling older adults: An fMRI study Alzheimers & Dementia. 9: 397. DOI: 10.1016/J.Jalz.2013.05.785 |
0.532 |
|
2013 |
Langbaum J, High N, Aisen P, Albert M, Brown K, Comer M, Cummings J, Manly J, Petersen R, Sperling R, Strobel G, Weiner M, Tariot P, Reiman E. Development and implementation of the National Alzheimer's Prevention Registry Alzheimers & Dementia. 9: 280. DOI: 10.1016/J.Jalz.2013.05.560 |
0.483 |
|
2013 |
Gu Y, Scarmeas N, Cosentino SA, Brandt J, Albert M, Blacker D, Dubois B, Mayeux R, Stern Y. P1-157: Body mass change in Alzheimer's disease Alzheimer's & Dementia. 9: P206-P207. DOI: 10.1016/J.Jalz.2013.05.380 |
0.335 |
|
2013 |
Miller MI, Younes L, Ratnanather J, Brown T, Wang M, Lu Y, Li S, Pettigrew C, Mori S, Albert M. Medial temporal lobe changes preceding symptom onset of mild cognitive impairment: The BIOCARD Cohort Alzheimers & Dementia. 9: 54. DOI: 10.1016/J.Jalz.2013.05.091 |
0.374 |
|
2013 |
Soldan A, Pettigrew C, Wang M, Li S, Lu Y, Albert M, Selnes O. O1-04-06: Relationship of cognitive reserve and APOE status to clinical symptom onset of mild cognitive impairment: The BIOCARD Cohort Alzheimer's & Dementia. 9: P134-P134. DOI: 10.1016/J.Jalz.2013.04.072 |
0.378 |
|
2012 |
Miller MI, Younes L, Ratnanather JT, Brown T, Reigel T, Trinh H, Tang X, Barker P, Mori S, Albert M. Amygdala Atrophy in MCI/Alzheimer's Disease in the BIOCARD cohort based on Diffeomorphic Morphometry. Medical Image Computing and Computer-Assisted Intervention : Miccai ... International Conference On Medical Image Computing and Computer-Assisted Intervention. 2012: 155-166. PMID 24955432 |
0.312 |
|
2012 |
Tighe SK, Oishi K, Mori S, Smith GS, Albert M, Lyketsos CG, Mielke MM. Diffusion tensor imaging of neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's dementia. The Journal of Neuropsychiatry and Clinical Neurosciences. 24: 484-8. PMID 23224456 DOI: 10.1176/Appi.Neuropsych.11120375 |
0.445 |
|
2012 |
Mielke MM, Bandaru VV, Haughey NJ, Xia J, Fried LP, Yasar S, Albert M, Varma V, Harris G, Schneider EB, Rabins PV, Bandeen-Roche K, Lyketsos CG, Carlson MC. Serum ceramides increase the risk of Alzheimer disease: the Women's Health and Aging Study II. Neurology. 79: 633-41. PMID 22815558 DOI: 10.1212/Wnl.0B013E318264E380 |
0.413 |
|
2012 |
Bakker A, Krauss GL, Albert MS, Speck CL, Jones LR, Stark CE, Yassa MA, Bassett SS, Shelton AL, Gallagher M. Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment. Neuron. 74: 467-74. PMID 22578498 DOI: 10.1016/J.Neuron.2012.03.023 |
0.406 |
|
2012 |
Mielke MM, Okonkwo OC, Oishi K, Mori S, Tighe S, Miller MI, Ceritoglu C, Brown T, Albert M, Lyketsos CG. Fornix integrity and hippocampal volume predict memory decline and progression to Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 8: 105-13. PMID 22404852 DOI: 10.1016/J.Jalz.2011.05.2416 |
0.426 |
|
2012 |
Bakken TE, Roddey JC, Djurovic S, Akshoomoff N, Amaral DG, Bloss CS, Casey BJ, Chang L, Ernst TM, Gruen JR, Jernigan TL, Kaufmann WE, Kenet T, Kennedy DN, Kuperman JM, ... ... Albert M, et al. Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans. Proceedings of the National Academy of Sciences of the United States of America. 109: 3985-90. PMID 22343285 DOI: 10.1073/Pnas.1105829109 |
0.687 |
|
2012 |
Moghekar A, Goh J, Li M, Albert M, O'Brien RJ. Cerebrospinal fluid Aβ and tau level fluctuation in an older clinical cohort. Archives of Neurology. 69: 246-50. PMID 22332192 DOI: 10.1001/Archneurol.2011.732 |
0.373 |
|
2012 |
Okereke OI, Pantoja-Galicia N, Copeland M, Hyman BT, Wanggaard T, Albert MS, Betensky RA, Blacker D. The SIST-M: predictive validity of a brief structured clinical dementia rating interview. Alzheimer Disease and Associated Disorders. 26: 225-31. PMID 21986342 DOI: 10.1097/Wad.0B013E318231Cd30 |
0.38 |
|
2012 |
Oishi K, Mielke MM, Albert M, Lyketsos CG, Mori S. The fornix sign: a potential sign for Alzheimer's disease based on diffusion tensor imaging. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 22: 365-74. PMID 21848679 DOI: 10.1111/J.1552-6569.2011.00633.X |
0.425 |
|
2012 |
Oishi K, Mielke M, Albert M, Lyketsos C, Mori S. Neuroanatomical Correlates of Cognitive and Neuropsychiatric Worsening in Alzheimer's Disease: Whole-Brain Longitudinal DTI Analysis (P03.092) Neurology. 78: P03.092-P03.092. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P03.092 |
0.443 |
|
2012 |
Mckhann GM, Albert MS, Sperling RA. Changing diagnostic concepts of Alzheimer's disease Advances in Biological Psychiatry. 28: 115-121. DOI: 10.1159/000335402 |
0.434 |
|
2012 |
Aisen P, Thomas R, Carrillo M, Mohs R, Petersen R, Siuciak J, Albert M. The Placebo Data Analysis in Alzheimer's Disease (AD) and Mild Cognitive Impairment (MCI) Clinical Trials Project: Overview of progress in trial data collection, and key findings from the pooled Alzheimer's disease trial datasets Alzheimers & Dementia. 8: 590. DOI: 10.1016/J.Jalz.2012.05.1609 |
0.356 |
|
2011 |
Silverberg NB, Ryan LM, Carrillo MC, Sperling R, Petersen RC, Posner HB, Snyder PJ, Hilsabeck R, Gallagher M, Raber J, Rizzo A, Possin K, King J, Kaye J, Ott BR, ... Albert MS, et al. Assessment of cognition in early dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: e60-e76. PMID 23559893 DOI: 10.1016/J.Jalz.2011.05.001 |
0.58 |
|
2011 |
Reiman EM, McKhann GM, Albert MS, Sperling RA, Petersen RC, Blacker D. Clinical impact of updated diagnostic and research criteria for Alzheimer's disease. The Journal of Clinical Psychiatry. 72: e37. PMID 22244033 DOI: 10.4088/Jcp.10087Tx2C |
0.554 |
|
2011 |
Albert MS. Changes in cognition. Neurobiology of Aging. 32: S58-63. PMID 22078174 DOI: 10.1016/J.Neurobiolaging.2011.09.010 |
0.465 |
|
2011 |
Oishi K, Mielke MM, Albert M, Lyketsos CG, Mori S. DTI analyses and clinical applications in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 26: 287-96. PMID 21971468 DOI: 10.3233/Jad-2011-0007 |
0.428 |
|
2011 |
Reiman EM, McKhann GM, Albert MS, Sperling RA, Petersen RC, Blacker D. Alzheimer's disease: implications of the updated diagnostic and research criteria. The Journal of Clinical Psychiatry. 72: 1190-6. PMID 21951985 DOI: 10.4088/Jcp.10087Co1C |
0.5 |
|
2011 |
Oishi K, Akhter K, Mielke M, Ceritoglu C, Zhang J, Jiang H, Li X, Younes L, Miller MI, van Zijl PC, Albert M, Lyketsos CG, Mori S. Multi-modal MRI analysis with disease-specific spatial filtering: initial testing to predict mild cognitive impairment patients who convert to Alzheimer's disease. Frontiers in Neurology. 2: 54. PMID 21904533 DOI: 10.3389/Fneur.2011.00054 |
0.454 |
|
2011 |
Snyder PJ, Jackson CE, Petersen RC, Khachaturian AS, Kaye J, Albert MS, Weintraub S. Assessment of cognition in mild cognitive impairment: a comparative study. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: 338-55. PMID 21575877 DOI: 10.1016/J.Jalz.2011.03.009 |
0.421 |
|
2011 |
Smith EE, Salat DH, Jeng J, McCreary CR, Fischl B, Schmahmann JD, Dickerson BC, Viswanathan A, Albert MS, Blacker D, Greenberg SM. Correlations between MRI white matter lesion location and executive function and episodic memory. Neurology. 76: 1492-9. PMID 21518999 DOI: 10.1212/Wnl.0B013E318217E7C8 |
0.595 |
|
2011 |
Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: 270-9. PMID 21514249 DOI: 10.1016/j.jalz.2011.03.008 |
0.368 |
|
2011 |
Jack CR, Albert MS, Knopman DS, McKhann GM, Sperling RA, Carrillo MC, Thies B, Phelps CH. Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: 257-62. PMID 21514247 DOI: 10.1016/J.Jalz.2011.03.004 |
0.554 |
|
2011 |
Dickerson BC, Stoub TR, Shah RC, Sperling RA, Killiany RJ, Albert MS, Hyman BT, Blacker D, Detoledo-Morrell L. Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults. Neurology. 76: 1395-402. PMID 21490323 DOI: 10.1212/Wnl.0B013E3182166E96 |
0.785 |
|
2011 |
Okereke OI, Copeland M, Hyman BT, Wanggaard T, Albert MS, Blacker D. The Structured Interview & Scoring Tool-Massachusetts Alzheimer's Disease Research Center (SIST-M): development, reliability, and cross-sectional validation of a brief structured clinical dementia rating interview. Archives of Neurology. 68: 343-50. PMID 21403019 DOI: 10.1001/Archneurol.2010.375 |
0.412 |
|
2011 |
Okonkwo OC, Mielke MM, Griffith HR, Moghekar AR, O'Brien RJ, Shaw LM, Trojanowski JQ, Albert MS. Cerebrospinal fluid profiles and prospective course and outcome in patients with amnestic mild cognitive impairment. Archives of Neurology. 68: 113-9. PMID 21220682 DOI: 10.1001/Archneurol.2010.334 |
0.427 |
|
2011 |
Zhu CW, Livote EE, Kahle-Wrobleski K, Scarmeas N, Albert M, Brandt J, Blacker D, Sano M, Stern Y. Utilization of antihypertensives, antidepressants, antipsychotics, and hormones in Alzheimer disease. Alzheimer Disease and Associated Disorders. 25: 144-8. PMID 20975515 DOI: 10.1097/Wad.0B013E3181Fcba68 |
0.367 |
|
2011 |
Yassa MA, Lacy JW, Stark SM, Albert MS, Gallagher M, Stark CE. Pattern separation deficits associated with increased hippocampal CA3 and dentate gyrus activity in nondemented older adults. Hippocampus. 21: 968-79. PMID 20865732 DOI: 10.1002/Hipo.20808 |
0.305 |
|
2011 |
Bakker A, Krauss G, Albert M, Stark C, Bassett S, Gallagher M. P4-349: Clinical efficacy of low dose levetiracetam for hippocampal hyperactivity in amnestic mild cognitive impairment Alzheimer's & Dementia. 7: e34-e34. DOI: 10.1016/J.Jalz.2011.09.095 |
0.36 |
|
2011 |
Dickerson B, Albert M, Blacker D, Shah R, DeToledo-Morrell L, Killiany R, Sperling R, Stoub T, Hyman B. O1-07-01: Alzheimer's-signature MRI biomarker predicts likelihood of Alzheimer's dementia in cognitively normal adults Alzheimer's & Dementia. 7: S109-S109. DOI: 10.1016/j.jalz.2011.05.272 |
0.326 |
|
2011 |
Mielke M, Bandaru VVR, Xia J, Haughey N, Yasar S, Albert M, Varma V, Harris G, Schneider E, Bandeen-Roche K, Fried L, Lyketsos C, Carlson M. P3-283: Serum ceramides predict incident Alzheimer's disease: The women's health and aging study (WHAS) II Alzheimer's & Dementia. 7: S607-S607. DOI: 10.1016/J.Jalz.2011.05.1725 |
0.33 |
|
2011 |
Dickerson B, Stoub T, Shah R, Sperling R, Killiany R, Albert M, Hyman B, Blacker D, DeToledo-Morrell L. IC-P-040: Alzheimer's signature MRI biomarker predicts likelihood of Alzheimer's dementia in cognitively normal adults Alzheimer's & Dementia. 7: S24-S25. DOI: 10.1016/J.Jalz.2011.05.109 |
0.749 |
|
2010 |
Mielke MM, Haughey NJ, Ratnam Bandaru VV, Schech S, Carrick R, Carlson MC, Mori S, Miller MI, Ceritoglu C, Brown T, Albert M, Lyketsos CG. Plasma ceramides are altered in mild cognitive impairment and predict cognitive decline and hippocampal volume loss. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 6: 378-85. PMID 20813340 DOI: 10.1016/J.Jalz.2010.03.014 |
0.452 |
|
2010 |
Zhu CW, Livote EE, Kahle-Wrobleski K, Scarmeas N, Albert M, Brandt J, Blacker D, Sano M, Stern Y. Longitudinal medication usage in Alzheimer disease patients. Alzheimer Disease and Associated Disorders. 24: 354-9. PMID 20625271 DOI: 10.1097/Wad.0B013E3181E6A17A |
0.425 |
|
2010 |
Jiang L, Kim M, Chodkowski B, Donahue MJ, Pekar JJ, Van Zijl PC, Albert M. Reliability and reproducibility of perfusion MRI in cognitively normal subjects. Magnetic Resonance Imaging. 28: 1283-9. PMID 20573464 DOI: 10.1016/J.Mri.2010.05.002 |
0.343 |
|
2010 |
Qiu A, Oishi K, Miller MI, Lyketsos CG, Mori S, Albert M. Surface-based analysis on shape and fractional anisotropy of white matter tracts in Alzheimer's disease. Plos One. 5: e9811. PMID 20339558 DOI: 10.1371/Journal.Pone.0009811 |
0.377 |
|
2010 |
Yassa MA, Stark SM, Bakker A, Albert MS, Gallagher M, Stark CE. High-resolution structural and functional MRI of hippocampal CA3 and dentate gyrus in patients with amnestic Mild Cognitive Impairment. Neuroimage. 51: 1242-52. PMID 20338246 DOI: 10.1016/J.Neuroimage.2010.03.040 |
0.333 |
|
2010 |
Khachaturian ZS, Barnes D, Einstein R, Johnson S, Lee V, Roses A, Sager MA, Shankle WR, Snyder PJ, Petersen RC, Schellenberg G, Trojanowski J, Aisen P, Albert MS, Breitner JC, et al. Developing a national strategy to prevent dementia: Leon Thal Symposium 2009. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 6: 89-97. PMID 20298968 DOI: 10.1016/J.Jalz.2010.01.008 |
0.416 |
|
2010 |
Pihlajamäki M, O' Keefe K, Bertram L, Tanzi RE, Dickerson BC, Blacker D, Albert MS, Sperling RA. Evidence of altered posteromedial cortical FMRI activity in subjects at risk for Alzheimer disease. Alzheimer Disease and Associated Disorders. 24: 28-36. PMID 19571734 DOI: 10.1097/Wad.0B013E3181A785C9 |
0.675 |
|
2010 |
Mielke MM, Okonkwo OC, Mori S, Oishi K, Miller MI, Ceritoglu C, Brown T, Albert M, Lyketsos CG. Fornix fractional anisotropy and hippocampal volume, alone and in combination, predict conversion from MCI to Alzheimer's disease Alzheimer's & Dementia. 6: S288. DOI: 10.1016/J.Jalz.2010.05.948 |
0.394 |
|
2010 |
Zhu C, Livote E, Kahle-Wrobleski K, Scarmeas N, Albert M, Brandt J, Blacker D, Sano M, Stern Y. P2-073: Longitudinal patterns of medication use in Alzheimer's disease Alzheimer's & Dementia. 6: S334-S334. DOI: 10.1016/J.Jalz.2010.05.1119 |
0.335 |
|
2010 |
Mielke MM, Okonkwo OC, Mori S, Oishi K, Miller MI, Ceritoglu C, Brown T, Albert M, Lyketsos CG. IC-P-031: Fornix fractional anisotropy and hippocampal volume, alone and in combination, predict conversion from MCI to AD Alzheimer's & Dementia. 6: S16-S16. DOI: 10.1016/J.Jalz.2010.05.045 |
0.346 |
|
2009 |
Brandt J, Aretouli E, Neijstrom E, Samek J, Manning K, Albert MS, Bandeen-Roche K. Selectivity of executive function deficits in mild cognitive impairment. Neuropsychology. 23: 607-18. PMID 19702414 DOI: 10.1037/A0015851 |
0.414 |
|
2009 |
Scarmeas N, Honig LS, Choi H, Cantero J, Brandt J, Blacker D, Albert M, Amatniek JC, Marder K, Bell K, Hauser WA, Stern Y. Seizures in Alzheimer disease: who, when, and how common? Archives of Neurology. 66: 992-7. PMID 19667221 DOI: 10.1001/Archneurol.2009.130 |
0.315 |
|
2009 |
Mielke MM, Kozauer NA, Chan KCG, George M, Toroney J, Zerrate M, Bandeen-Roche K, Wang MC, vanZijl P, Pekar JJ, Mori S, Lyketsos CG, Albert M. Regionally-specific diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease Neuroimage. 46: 47-55. PMID 19457371 DOI: 10.1016/J.Neuroimage.2009.01.054 |
0.476 |
|
2009 |
Ceritoglu C, Oishi K, Li X, Chou MC, Younes L, Albert M, Lyketsos C, van Zijl PC, Miller MI, Mori S. Multi-contrast large deformation diffeomorphic metric mapping for diffusion tensor imaging. Neuroimage. 47: 618-27. PMID 19398016 DOI: 10.1016/J.Neuroimage.2009.04.057 |
0.306 |
|
2009 |
Oishi K, Faria A, Jiang H, Li X, Akhter K, Zhang J, Hsu JT, Miller MI, van Zijl PC, Albert M, Lyketsos CG, Woods R, Toga AW, Pike GB, Rosa-Neto P, et al. Atlas-based whole brain white matter analysis using large deformation diffeomorphic metric mapping: application to normal elderly and Alzheimer's disease participants. Neuroimage. 46: 486-99. PMID 19385016 DOI: 10.1016/J.Neuroimage.2009.01.002 |
0.315 |
|
2009 |
Jovicich J, Czanner S, Han X, Salat D, van der Kouwe A, Quinn B, Pacheco J, Albert M, Killiany R, Blacker D, Maguire P, Rosas D, Makris N, Gollub R, Dale A, et al. MRI-derived measurements of human subcortical, ventricular and intracranial brain volumes: Reliability effects of scan sessions, acquisition sequences, data analyses, scanner upgrade, scanner vendors and field strengths. Neuroimage. 46: 177-92. PMID 19233293 DOI: 10.1016/J.Neuroimage.2009.02.010 |
0.495 |
|
2009 |
Desikan RS, Cabral HJ, Fischl B, Guttmann CR, Blacker D, Hyman BT, Albert MS, Killiany RJ. Temporoparietal MR imaging measures of atrophy in subjects with mild cognitive impairment that predict subsequent diagnosis of Alzheimer disease. Ajnr. American Journal of Neuroradiology. 30: 532-8. PMID 19112067 DOI: 10.3174/Ajnr.A1397 |
0.467 |
|
2009 |
Zhu CW, Kahle-Wrobleski K, Livote E, Scarmeas N, Albert M, Brandt J, Blacker D, Sano M, Stern Y. Longitudinal medication usage in Alzheimer's disease patients Alzheimers & Dementia. 5: 407. DOI: 10.1016/J.Jalz.2009.04.990 |
0.348 |
|
2009 |
Mielke MM, Haughey N, Bandaru VVR, Miller MI, Mori S, Schech S, Albert M, Lyketsos CG. P3-040: Plasma ceramides predict hippocampal atrophy and progression in memory impairment among amnestic Mild Cognitive Impairment participants Alzheimer's & Dementia. 5: P351-P352. DOI: 10.1016/J.Jalz.2009.04.1217 |
0.386 |
|
2008 |
Bain LJ, Jedrziewski K, Morrison-Bogorad M, Albert M, Cotman C, Hendrie H, Trojanowski JQ. Healthy brain aging: A meeting report from the Sylvan M. Cohen Annual Retreat of the University of Pennsylvania Institute on Aging Alzheimer's and Dementia. 4: 443-446. PMID 18945646 DOI: 10.1016/J.Jalz.2008.08.006 |
0.406 |
|
2008 |
Scherer RK, Scarmeas N, Brandt J, Blacker D, Albert MS, Stern Y. The relation of patient dependence to home health aide use in Alzheimer's disease. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 63: 1005-9. PMID 18840808 DOI: 10.1093/Gerona/63.9.1005 |
0.373 |
|
2008 |
Brickman AM, Honig LS, Scarmeas N, Tatarina O, Sanders L, Albert MS, Brandt J, Blacker D, Stern Y. Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease. Archives of Neurology. 65: 1202-8. PMID 18779424 DOI: 10.1001/Archneur.65.9.1202 |
0.456 |
|
2008 |
Desikan RS, Fischl B, Cabral HJ, Kemper TL, Guttmann CR, Blacker D, Hyman BT, Albert MS, Killiany RJ. MRI measures of temporoparietal regions show differential rates of atrophy during prodromal AD. Neurology. 71: 819-25. PMID 18672473 DOI: 10.1212/01.Wnl.0000320055.57329.34 |
0.467 |
|
2008 |
Khachaturian ZS, Petersen RC, Gauthier S, Buckholtz N, Corey-Bloom JP, Evans B, Fillit H, Foster N, Greenberg B, Grundman M, Sano M, Simpkins J, Schneider LS, Weiner MW, Galasko D, ... ... Albert M, et al. A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 4: 156-63. PMID 18631960 DOI: 10.1016/J.Jalz.2008.03.005 |
0.376 |
|
2008 |
Albert M. Chapter 27 Neuropsychology of Alzheimer's disease Handbook of Clinical Neurology. 88: 511-525. PMID 18631710 DOI: 10.1016/S0072-9752(07)88027-4 |
0.484 |
|
2008 |
Steinerman JR, Irizarry M, Scarmeas N, Raju S, Brandt J, Albert M, Blacker D, Hyman B, Stern Y. Distinct pools of beta-amyloid in Alzheimer disease-affected brain: a clinicopathologic study. Archives of Neurology. 65: 906-12. PMID 18625856 DOI: 10.1001/Archneur.65.7.906 |
0.388 |
|
2008 |
Cosentino S, Scarmeas N, Helzner E, Glymour MM, Brandt J, Albert M, Blacker D, Stern Y. APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease. Neurology. 70: 1842-9. PMID 18401023 DOI: 10.1212/01.Wnl.0000304038.37421.Cc |
0.484 |
|
2008 |
Jack CR, Bernstein MA, Fox NC, Thompson P, Alexander G, Harvey D, Borowski B, Britson PJ, L Whitwell J, Ward C, Dale AM, Felmlee JP, Gunter JL, Hill DL, Killiany R, ... ... Albert M, et al. The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. Journal of Magnetic Resonance Imaging : Jmri. 27: 685-91. PMID 18302232 DOI: 10.1002/Jmri.21049 |
0.375 |
|
2008 |
Holland CM, Smith EE, Csapo I, Gurol ME, Brylka DA, Killiany RJ, Blacker D, Albert MS, Guttmann CR, Greenberg SM. Spatial distribution of white-matter hyperintensities in Alzheimer disease, cerebral amyloid angiopathy, and healthy aging. Stroke; a Journal of Cerebral Circulation. 39: 1127-33. PMID 18292383 DOI: 10.1161/Strokeaha.107.497438 |
0.397 |
|
2008 |
Smith EE, Egorova S, Blacker D, Killiany RJ, Muzikansky A, Dickerson BC, Tanzi RE, Albert MS, Greenberg SM, Guttmann CR. Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia. Archives of Neurology. 65: 94-100. PMID 18195145 DOI: 10.1001/Archneurol.2007.23 |
0.618 |
|
2008 |
Dickerson BC, Fenstermacher E, Salat DH, Wolk DA, Maguire RP, Desikan R, Pacheco J, Quinn BT, Van der Kouwe A, Greve DN, Blacker D, Albert MS, Killiany RJ, Fischl B. Detection of cortical thickness correlates of cognitive performance: Reliability across MRI scan sessions, scanners, and field strengths. Neuroimage. 39: 10-8. PMID 17942325 DOI: 10.1016/J.Neuroimage.2007.08.042 |
0.556 |
|
2008 |
Mielke MM, Bandaru VV, Haughey NJ, Schech S, Chu M, Albert M, Bandeen-Roche K, Lyketsos CG. P1-360: Plasma ceramides are altered early in the course of Alzheimer's disease Alzheimer's & Dementia. 4: T324-T324. DOI: 10.1016/J.Jalz.2008.05.942 |
0.343 |
|
2008 |
Blacker D, Wanggaard T, Copeland M, Betensky R, Hyman BT, Albert MS, Okereke OI. P1-180: Reliability and predictive validity of questionnaire items for development of a brief, structured clinical dementia rating interview Alzheimer's & Dementia. 4: T261-T261. DOI: 10.1016/J.Jalz.2008.05.768 |
0.303 |
|
2008 |
Zhu C, Leibman C, McLaughlin T, Scarmeas N, Albert M, Brandt J, Blacker D, Sano M, Stern Y. O2-07-05: Patient dependence, function, and changes in cost of care in Alzheimer's disease Alzheimer's & Dementia. 4: T147-T147. DOI: 10.1016/J.Jalz.2008.05.362 |
0.308 |
|
2008 |
Yassa MA, Albert MS, Gallagher M, Stark CE. IC-P1-069: Functional MRI of hippocampal subfields in healthy aging and Mild Cognitive Impairment Alzheimer's & Dementia. 4: T36-T36. DOI: 10.1016/J.Jalz.2008.05.2511 |
0.364 |
|
2008 |
Zhu C, Scarmeas N, Albert M, Brandt J, Blacker D, Sano M, Stern Y. AbstractPoster presentation: Tuesday posterP3-442: Comparison of costs of care between patients with Alzheimer's disease and dementia with Lewy bodies Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.2012 |
0.357 |
|
2007 |
Scarmeas N, Brandt J, Blacker D, Albert M, Hadjigeorgiou G, Dubois B, Devanand D, Honig L, Stern Y. Disruptive behavior as a predictor in Alzheimer disease. Archives of Neurology. 64: 1755-61. PMID 18071039 DOI: 10.1001/Archneur.64.12.1755 |
0.443 |
|
2007 |
Dickerson BC, Sperling RA, Hyman BT, Albert MS, Blacker D. Clinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment. Archives of General Psychiatry. 64: 1443-50. PMID 18056553 DOI: 10.1001/Archpsyc.64.12.1443 |
0.687 |
|
2007 |
Albert MS. Changing the trajectory of cognitive decline? The New England Journal of Medicine. 357: 502-3. PMID 17671260 DOI: 10.1056/Nejmcibr073273 |
0.321 |
|
2007 |
Dickerson BC, Miller SL, Greve DN, Dale AM, Albert MS, Schacter DL, Sperling RA. Prefrontal-hippocampal-fusiform activity during encoding predicts intraindividual differences in free recall ability: an event-related functional-anatomic MRI study. Hippocampus. 17: 1060-70. PMID 17604356 DOI: 10.1002/Hipo.20338 |
0.589 |
|
2007 |
McQueen MB, Bertram L, Lange C, Becker KD, Albert MS, Tanzi RE, Blacker D. Exploring candidate gene associations with neuropsychological performance. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 144: 987-91. PMID 17579348 DOI: 10.1002/Ajmg.B.30500 |
0.433 |
|
2007 |
Blacker D, Lee H, Muzikansky A, Martin EC, Tanzi R, McArdle JJ, Moss M, Albert M. Neuropsychological measures in normal individuals that predict subsequent cognitive decline. Archives of Neurology. 64: 862-71. PMID 17562935 DOI: 10.1001/Archneur.64.6.862 |
0.463 |
|
2007 |
Albert M, Blacker D, Moss MB, Tanzi R, McArdle JJ. Longitudinal change in cognitive performance among individuals with mild cognitive impairment. Neuropsychology. 21: 158-69. PMID 17402816 DOI: 10.1037/0894-4105.21.2.158 |
0.412 |
|
2007 |
Moscarillo TJ, Holt H, Perman M, Goldberg S, Cortellini L, Stoler JM, DeJong W, Miles BJ, Albert MS, Go RC, Blacker D. Knowledge of and attitudes about Alzheimer disease genetics: report of a pilot survey and two focus groups. Community Genetics. 10: 97-102. PMID 17380059 DOI: 10.1159/000099087 |
0.363 |
|
2007 |
Johnson KA, Moran EK, Becker JA, Blacker D, Fischman AJ, Albert MS. Single photon emission computed tomography perfusion differences in mild cognitive impairment. Journal of Neurology, Neurosurgery, and Psychiatry. 78: 240-7. PMID 17056633 DOI: 10.1136/Jnnp.2006.096800 |
0.389 |
|
2007 |
Desikan RS, Fischl B, Cabral HJ, Kemper TL, Guttmann CR, Blacker D, Hyman BT, Albert MS, Killiany RJ. P-030: MRI-based longitudinal measures of temporoparietal regions show differential rates of atrophy during prodromal Alzheimer's disease Alzheimer's & Dementia. 3: S106-S106. DOI: 10.1016/J.Jalz.2007.04.246 |
0.384 |
|
2007 |
Albert M. PL3-01: Lifestyle factors & cognitive decline Alzheimers & Dementia. 3. DOI: 10.1016/J.Jalz.2007.04.014 |
0.358 |
|
2006 |
Hendrie HC, Albert MS, Butters MA, Gao S, Knopman DS, Launer LJ, Yaffe K, Cuthbert BN, Edwards E, Wagster MV. The NIH Cognitive and Emotional Health Project. Report of the Critical Evaluation Study Committee. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 2: 12-32. PMID 19595852 DOI: 10.1016/J.Jalz.2005.11.004 |
0.351 |
|
2006 |
Albert MS, Blacker D. Mild cognitive impairment and dementia. Annual Review of Clinical Psychology. 2: 379-88. PMID 17716075 DOI: 10.1146/Annurev.Clinpsy.1.102803.144039 |
0.413 |
|
2006 |
Stavitsky K, Brickman AM, Scarmeas N, Torgan RL, Tang MX, Albert M, Brandt J, Blacker D, Stern Y. The progression of cognition, psychiatric symptoms, and functional abilities in dementia with Lewy bodies and Alzheimer disease. Archives of Neurology. 63: 1450-6. PMID 17030662 DOI: 10.1001/Archneur.63.10.1450 |
0.467 |
|
2006 |
Celone KA, Calhoun VD, Dickerson BC, Atri A, Chua EF, Miller SL, DePeau K, Rentz DM, Selkoe DJ, Blacker D, Albert MS, Sperling RA. Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: an independent component analysis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 10222-31. PMID 17021177 DOI: 10.1523/Jneurosci.2250-06.2006 |
0.679 |
|
2006 |
Espeland MA, Rapp SR, Robertson J, Granek I, Murphy C, Albert M, Bassford TL. Benchmarks for designing two-stage studies using modified mini-mental state examinations: experience from the Women's Health Initiative Memory Study Clinical Trials. 3: 99-106. PMID 16773952 DOI: 10.1191/1740774506Cn140Oa |
0.333 |
|
2006 |
Amatniek JC, Hauser WA, DelCastillo-Castaneda C, Jacobs DM, Marder K, Bell K, Albert M, Brandt J, Stern Y. Incidence and predictors of seizures in patients with Alzheimer's disease. Epilepsia. 47: 867-72. PMID 16686651 DOI: 10.1111/J.1528-1167.2006.00554.X |
0.334 |
|
2006 |
Han X, Jovicich J, Salat D, van der Kouwe A, Quinn B, Czanner S, Busa E, Pacheco J, Albert M, Killiany R, Maguire P, Rosas D, Makris N, Dale A, Dickerson B, et al. Reliability of MRI-derived measurements of human cerebral cortical thickness: the effects of field strength, scanner upgrade and manufacturer. Neuroimage. 32: 180-94. PMID 16651008 DOI: 10.1016/J.Neuroimage.2006.02.051 |
0.502 |
|
2006 |
Desikan RS, Ségonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, Buckner RL, Dale AM, Maguire RP, Hyman BT, Albert MS, Killiany RJ. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage. 31: 968-80. PMID 16530430 DOI: 10.1016/J.Neuroimage.2006.01.021 |
0.504 |
|
2006 |
Holtzer R, Irizarry MC, Sanders J, Hyman BT, Wegesin DJ, Riba A, Brandt J, Albert M, Stern Y. Relation of quantitative indexes of concurrent alpha-synuclein abnormalities to clinical outcome in autopsy-proven Alzheimer disease. Archives of Neurology. 63: 226-30. PMID 16476811 DOI: 10.1001/Archneur.63.2.226 |
0.46 |
|
2006 |
Zaitchik D, Koff E, Brownell H, Winner E, Albert M. Inference of beliefs and emotions in patients with Alzheimer's disease. Neuropsychology. 20: 11-20. PMID 16460218 DOI: 10.1037/0894-4105.20.1.11 |
0.358 |
|
2006 |
Rand-Giovannetti E, Chua EF, Driscoll AE, Schacter DL, Albert MS, Sperling RA. Hippocampal and neocortical activation during repetitive encoding in older persons. Neurobiology of Aging. 27: 173-82. PMID 16298252 DOI: 10.1016/J.Neurobiolaging.2004.12.013 |
0.498 |
|
2006 |
Soldan A, Pettigrew C, Zhu Y, Singh B, Fletcher E, Martinez O, Wang M, DeCarli CS, Albert MS. O2-13-04: WHITE MATTER HYPERINTENSITIES AND CSF BIOMARKERS IN RELATION TO CLINICAL SYMPTOM ONSET IN PRECLINICAL ALZHEIMER'S DISEASE Alzheimer's & Dementia. 14: P654-P654. DOI: 10.1016/J.Jalz.2018.06.2715 |
0.347 |
|
2006 |
Pettigrew C, Wu D, Soldan A, Oishi K, Miller M, Mori S, Albert MS. P2-432: REGIONAL WHITE MATTER HYPERINTENSITIES ARE DIFFERENTIALLY RELATED TO MEASURES OF VASCULAR RISK AND ALZHEIMER'S DISEASE Alzheimer's & Dementia. 14: P878-P878. DOI: 10.1016/J.Jalz.2018.06.1124 |
0.364 |
|
2006 |
Dickerson BC, Hevelone N, Sperling RA, Albert MS, Blacker D. P2-073: Prediction of cognitive decline among very mild MCI cases Alzheimer's & Dementia. 2: S254-S254. DOI: 10.1016/J.Jalz.2006.05.910 |
0.628 |
|
2006 |
Pihlajamaki M, Miller SM, DePeau KM, Celone KA, Bertram L, Tanzi RE, Dickerson BC, Albert MS, Blacker D, Sperling RA. O4-01-02: The effect of APOE-4
on fMRI deactivation in older controls, MCI subjects and AD patients Alzheimer's & Dementia. 2: S74-S75. DOI: 10.1016/J.Jalz.2006.05.292 |
0.621 |
|
2006 |
Sperling R, Depeau K, Miller S, Chua E, Rentz D, Dickerson B, Atri A, Selkoe D, Johnson K, Calhoun V, Albert M, Celone K. Ic-101-05 Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.2344 |
0.516 |
|
2006 |
Honig LS, Scarmeas N, Brickman AM, Albert MS, Brandt J, Blacker D, Stern Y. IC-P-123: Greater cerebral atrophy predicts more rapid cognitive decline in Alzheimer's disease Alzheimer's & Dementia. 2: S701-S702. DOI: 10.1016/J.Jalz.2006.05.2329 |
0.429 |
|
2006 |
DePeau KM, Pihlajamaki M, Diamond EL, Miller SM, Chua EF, Dickerson BC, Albert MS, Blacker D, Sperling RA. IC-P-086: Failure of hippocampal habituation in mild cognitive impairment and Alzheimer's disease Alzheimer's & Dementia. 2: S687-S688. DOI: 10.1016/J.Jalz.2006.05.2291 |
0.555 |
|
2006 |
Desikan RS, Han X, Cabral HJ, Fischl B, Blacker D, Guttmann CR, Albert MS, Killiany RJ. IC-P-082: Atrophy in the parietotemporal regions increases the risk of developing Alzheimer's disease: A longitudinal MRI study Alzheimer's & Dementia. 2: S686-S686. DOI: 10.1016/J.Jalz.2006.05.2287 |
0.369 |
|
2006 |
Pihlajamaki M, Miller SM, DePeau KM, Celone KA, Bertram L, Tanzi RE, Dickerson BC, Albert MS, Blacker D, Sperling RA. IC-P-071: The effect of APOE-4
on fMRI deactivation in older controls, MCI subjects and AD patients Alzheimer's & Dementia. 2: S681-S681. DOI: 10.1016/J.Jalz.2006.05.2276 |
0.627 |
|
2006 |
Irizarry MC, Muzikansky A, Lee H, Raju S, Bottiglieri T, Hyman BT, Albert MS, Deborah B. AbstractPoster presentation: Tuesday posterP3-100: Longitudinal changes in plasma Aβ42 positively correlate with progression of mild cognitive impairment Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.1367 |
0.384 |
|
2006 |
Desikan RS, Han X, Cabral HJ, Fischl B, Blacker D, Guttmann CR, Albert MS, Killiany RJ. P2-368: Atrophy in the parietotemporal regions increases the risk of developing Alzheimer's disease: A longitudinal MRI study Alzheimer's & Dementia. 2: S352-S352. DOI: 10.1016/J.Jalz.2006.05.1208 |
0.388 |
|
2006 |
Smith EE, Egorova S, Blacker D, Killiany R, Muzikansky A, Dickerson BC, Tanzi RE, Albert MS, Greenberg SM, Guttman CRG. IC-P-118: Vascular risks and MRI measures of white matter hyperintensities and brain atrophy in the prediction of cognitive decline Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.1197 |
0.357 |
|
2006 |
Sperling R, Depeau K, Miller S, Chua E, Dorene R, Dickerson B, Atri A, Selkoe D, Albert M, Calhoun V, Celone K. P2-302: FMRI alterations medial temporal and neocortical networks in MCI and AD Alzheimer's & Dementia. 2: S328-S329. DOI: 10.1016/J.Jalz.2006.05.1142 |
0.616 |
|
2006 |
Honig LS, Scarmeas N, Brickman AM, Albert MS, Brandt J, Blacker D, Stern Y. P2-266: Greater cerebral atrophy predicts more rapid cognitive decline in Alzheimer's disease Alzheimer's & Dementia. 2: S316-S316. DOI: 10.1016/J.Jalz.2006.05.1105 |
0.451 |
|
2005 |
Holtzer R, Scarmeas N, Wegesin DJ, Albert M, Brandt J, Dubois B, Hadjigeorgiou GM, Stern Y. Depressive symptoms in Alzheimer's disease: natural course and temporal relation to function and cognitive status. Journal of the American Geriatrics Society. 53: 2083-9. PMID 16398891 DOI: 10.1111/J.1532-5415.2005.00535.X |
0.385 |
|
2005 |
Scarmeas N, Brandt J, Albert M, Hadjigeorgiou G, Papadimitriou A, Dubois B, Sarazin M, Devanand D, Honig L, Marder K, Bell K, Wegesin D, Blacker D, Stern Y. Delusions and hallucinations are associated with worse outcome in Alzheimer disease. Archives of Neurology. 62: 1601-8. PMID 16216946 DOI: 10.1001/Archneur.62.10.1601 |
0.441 |
|
2005 |
Dickerson BC, Salat DH, Greve DN, Chua EF, Rand-Giovannetti E, Rentz DM, Bertram L, Mullin K, Tanzi RE, Blacker D, Albert MS, Sperling RA. Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology. 65: 404-11. PMID 16087905 DOI: 10.1212/01.Wnl.0000171450.97464.49 |
0.694 |
|
2005 |
Wedig MM, Rauch SL, Albert MS, Wright CI. Differential amygdala habituation to neutral faces in young and elderly adults. Neuroscience Letters. 385: 114-9. PMID 15961229 DOI: 10.1016/J.Neulet.2005.05.039 |
0.318 |
|
2005 |
Scarmeas N, Albert M, Brandt J, Blacker D, Hadjigeorgiou G, Papadimitriou A, Dubois B, Sarazin M, Wegesin D, Marder K, Bell K, Honig L, Stern Y. Motor signs predict poor outcomes in Alzheimer disease. Neurology. 64: 1696-703. PMID 15911793 DOI: 10.1212/01.Wnl.0000162054.15428.E9 |
0.399 |
|
2005 |
Sarazin M, Stern Y, Berr C, Riba A, Albert M, Brandt J, Dubois B. Neuropsychological predictors of dependency in patients with Alzheimer disease. Neurology. 64: 1027-31. PMID 15781821 DOI: 10.1212/01.Wnl.0000154529.53488.30 |
0.476 |
|
2005 |
Dickerson BC, Salat DH, Greve DN, Albert MS, Blacker D, Sperling RA. [P-095]: An fMRI investigation of memory-related medial temporal lobe activation in mild cognitive impairment prior to dementia Alzheimer's & Dementia. 1: S38-S38. DOI: 10.1016/J.Jalz.2005.06.169 |
0.662 |
|
2004 |
Zaitchik D, Koff E, Brownell H, Winner E, Albert M. Inference of mental states in patients with Alzheimer's disease. Cognitive Neuropsychiatry. 9: 301-13. PMID 16571588 DOI: 10.1080/13546800344000246 |
0.398 |
|
2004 |
McArdle JJ, Hamgami F, Jones K, Jolesz F, Kikinis R, Spiro A, Albert MS. Structural modeling of dynamic changes in memory and brain structure using longitudinal data from the normative aging study. The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences. 59: P294-304. PMID 15576857 DOI: 10.1093/Geronb/59.6.P294 |
0.3 |
|
2004 |
Lyketsos CG, Brandt J, Fishman P, Gloth M, Koliatsos V, Loreck D, McGuire M, Rabins PV, Wertheimer D, Schwartz J, Das A, Sachs G, Albert M, McConnell S, Thies W. Research consent for cognitively impaired adults: Recommendations for Institutional Review Boards and investigators Alzheimer Disease and Associated Disorders. 18: 171-175. PMID 15494623 DOI: 10.1097/01.Wad.0000137520.23370.56 |
0.377 |
|
2004 |
Chua EF, Rand-Giovannetti E, Schacter DL, Albert MS, Sperling RA. Dissociating confidence and accuracy: functional magnetic resonance imaging shows origins of the subjective memory experience. Journal of Cognitive Neuroscience. 16: 1131-42. PMID 15453969 DOI: 10.1162/0898929041920568 |
0.466 |
|
2004 |
Scarmeas N, Hadjigeorgiou GM, Papadimitriou A, Dubois B, Sarazin M, Brandt J, Albert M, Marder K, Bell K, Honig LS, Wegesin D, Stern Y. Motor signs during the course of Alzheimer disease. Neurology. 63: 975-82. PMID 15452286 DOI: 10.1212/01.Wnl.0000138440.39918.0C |
0.389 |
|
2004 |
Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Bäckman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, et al. Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. Journal of Internal Medicine. 256: 240-6. PMID 15324367 DOI: 10.1111/J.1365-2796.2004.01380.X |
0.408 |
|
2004 |
Dickerson BC, Salat DH, Bates JF, Atiya M, Killiany RJ, Greve DN, Dale AM, Stern CE, Blacker D, Albert MS, Sperling RA. Medial temporal lobe function and structure in mild cognitive impairment. Annals of Neurology. 56: 27-35. PMID 15236399 DOI: 10.1002/Ana.20163 |
0.661 |
|
2004 |
Ingelsson M, Fukumoto H, Newell KL, Growdon JH, Hedley-Whyte ET, Frosch MP, Albert MS, Hyman BT, Irizarry MC. Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain. Neurology. 62: 925-31. PMID 15037694 DOI: 10.1212/01.Wnl.0000115115.98960.37 |
0.387 |
|
2004 |
Lange N, Lake S, Sperling R, Brown J, Routledge C, Albert M, Heckers S. Two macroscopic and microscopic brain imaging studies of human hippocampus in early Alzheimer's disease and schizophrenia research. Statistics in Medicine. 23: 327-50. PMID 14716733 DOI: 10.1002/Sim.1720 |
0.496 |
|
2004 |
Sperling R, Dickerson B, Rand-Giovannetti E, Chua EF, Driscoll AE, Rentz D, Blacker D, Albert MS. P3-100 Increased medial temporal lobe FMRI activation in questionable AD compared to normal aging Neurobiology of Aging. 25: S383. DOI: 10.1016/S0197-4580(04)81252-1 |
0.623 |
|
2004 |
Honig LS, Scarmeas N, Riba A, Albert M, Brandt J, Stern Y. P3-090 MRI signal hyperintensities predict more rapid cognitive decline in Alzheimer's disease (AD) Neurobiology of Aging. 25: S379. DOI: 10.1016/S0197-4580(04)81242-9 |
0.471 |
|
2004 |
Desikan RS, Fischl B, Dale AM, Salat DH, Makris N, Buckner RL, Albert MS, Killiany R. P3-081 Development of automated identification of cortical regions on MRI scans in AD patients Neurobiology of Aging. 25: S376. DOI: 10.1016/S0197-4580(04)81233-8 |
0.365 |
|
2004 |
Irizarry MC, Fukumoto H, Daly E, Gunther J, Hyman BT, Albert MS, Blacker D. P3-009 Cross-sectional measures of plasma amyloid-beta protein do not correlate with functional status in prodromal Alzheimer's disease Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)81164-3 |
0.324 |
|
2004 |
Johnson KA, Moran EK, Becker JA, Killiany R, Blacker D, Fischman AL, Albert M. P2-240 Prediction of clinical stability vs. progression in questionable ad using perfusion spect Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)80986-2 |
0.344 |
|
2004 |
Dickerson BC, Salat DH, Bates JF, Atiya M, Killiany RJ, Greve DN, Dale AM, Stern CE, Blacker D, Albert MS, Sperling RA. P2-165 Functional and structural MRI in questionable AD: relationships to clinical impairment and future decline Neurobiology of Aging. 25: S272-S273. DOI: 10.1016/S0197-4580(04)80912-6 |
0.638 |
|
2004 |
Zaitchik D, Fitzpatrick K, Albert M. P1-057 Concepts of living things in patients with Alzheimer's disease Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)80371-3 |
0.375 |
|
2003 |
Sperling R, Chua E, Cocchiarella A, Rand-Giovannetti E, Poldrack R, Schacter DL, Albert M. Putting names to faces: successful encoding of associative memories activates the anterior hippocampal formation. Neuroimage. 20: 1400-10. PMID 14568509 DOI: 10.1016/S1053-8119(03)00391-4 |
0.452 |
|
2003 |
Atiya M, Hyman BT, Albert MS, Killiany R. Structural magnetic resonance imaging in established and prodromal Alzheimer disease: a review. Alzheimer Disease and Associated Disorders. 17: 177-95. PMID 14512832 DOI: 10.1097/00002093-200307000-00010 |
0.417 |
|
2003 |
Saunders AJ, Bertram L, Mullin K, Sampson AJ, Latifzai K, Basu S, Jones J, Kinney D, MacKenzie-Ingano L, Yu S, Albert MS, Moscarillo TJ, Go RC, Bassett SS, Daly MJ, et al. Genetic association of Alzheimer's disease with multiple polymorphisms in alpha-2-macroglobulin. Human Molecular Genetics. 12: 2765-76. PMID 12966032 DOI: 10.1093/Hmg/Ddg310 |
0.354 |
|
2003 |
Holtzer R, Wegesin DJ, Albert SM, Marder K, Bell K, Albert M, Brandt J, Stern Y. The rate of cognitive decline and risk of reaching clinical milestones in Alzheimer disease. Archives of Neurology. 60: 1137-42. PMID 12925372 DOI: 10.1001/Archneur.60.8.1137 |
0.451 |
|
2003 |
El Fakhri G, Kijewski MF, Johnson KA, Syrkin G, Killiany RJ, Becker JA, Zimmerman RE, Albert MS. MRI-guided SPECT perfusion measures and volumetric MRI in prodromal Alzheimer disease. Archives of Neurology. 60: 1066-72. PMID 12925361 DOI: 10.1001/Archneur.60.8.1066 |
0.415 |
|
2003 |
Holtzer R, Tang MX, Devanand DP, Albert SM, Wegesin DJ, Marder K, Bell K, Albert M, Brandt J, Stern Y. Psychopathological features in Alzheimer's disease: course and relationship with cognitive status. Journal of the American Geriatrics Society. 51: 953-60. PMID 12834515 DOI: 10.1046/J.1365-2389.2003.51308.X |
0.455 |
|
2003 |
Albert MS. Detection of very early Alzheimer disease through neuroimaging. Alzheimer Disease and Associated Disorders. 17: S63-5. PMID 12813213 DOI: 10.1097/00002093-200304002-00010 |
0.365 |
|
2003 |
Bretsky P, Guralnik JM, Launer L, Albert M, Seeman TE. The role of APOE-ε4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging Neurology. 60: 1077-1081. PMID 12682309 DOI: 10.1212/01.Wnl.0000055875.26908.24 |
0.423 |
|
2003 |
Copeland MP, Daly E, Hines V, Mastromauro C, Zaitchik D, Gunther J, Albert M. Psychiatric symptomatology and prodromal Alzheimer's disease. Alzheimer Disease and Associated Disorders. 17: 1-8. PMID 12621314 DOI: 10.1097/00002093-200301000-00001 |
0.385 |
|
2003 |
Blacker D, Bertram L, Saunders AJ, Moscarillo TJ, Albert MS, Wiener H, Perry RT, Collins JS, Harrell LE, Go RC, Mahoney A, Beaty T, Fallin MD, Avramopoulos D, Chase GA, et al. Results of a high-resolution genome screen of 437 Alzheimer's disease families. Human Molecular Genetics. 12: 23-32. PMID 12490529 DOI: 10.1093/Hmg/Ddg007 |
0.332 |
|
2003 |
Sperling RA, Bates JF, Chua EF, Cocchiarella AJ, Rentz DM, Rosen BR, Schacter DL, Albert MS. fMRI studies of associative encoding in young and elderly controls and mild Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 74: 44-50. PMID 12486265 DOI: 10.1136/Jnnp.74.1.44 |
0.53 |
|
2002 |
Weaver JD, Huang MH, Albert M, Harris T, Rowe JW, Seeman TE. Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging. Neurology. 59: 371-8. PMID 12177370 DOI: 10.1212/Wnl.59.3.371 |
0.341 |
|
2002 |
Brickman AM, Riba A, Bell K, Marder K, Albert M, Brandt J, Stern Y. Longitudinal assessment of patient dependence in Alzheimer disease Archives of Neurology. 59: 1304-1308. PMID 12164728 DOI: 10.1001/Archneur.59.8.1304 |
0.399 |
|
2002 |
Chodosh J, Reuben DB, Albert MS, Seeman TE. Predicting cognitive impairment in high-functioning community-dwelling older persons: MacArthur Studies of Successful Aging. Journal of the American Geriatrics Society. 50: 1051-60. PMID 12110065 DOI: 10.1046/J.1532-5415.2002.50260.X |
0.423 |
|
2002 |
Fillit HM, Butler RN, O'Connell AW, Albert MS, Birren JE, Cotman CW, Greenough WT, Gold PE, Kramer AF, Kuller LH, Perls TT, Sahagan BG, Tully T. Achieving and maintaining cognitive vitality with aging. Mayo Clinic Proceedings. 77: 681-96. PMID 12108606 DOI: 10.4065/77.7.681 |
0.595 |
|
2002 |
Killiany RJ, Hyman BT, Gomez-Isla T, Moss MB, Kikinis R, Jolesz F, Tanzi R, Jones K, Albert MS. MRI measures of entorhinal cortex vs hippocampus in preclinical AD. Neurology. 58: 1188-96. PMID 11971085 DOI: 10.1212/Wnl.58.8.1188 |
0.424 |
|
2002 |
Scarmeas N, Brandt J, Albert M, Devanand DP, Marder K, Bell K, Ciappa A, Tycko B, Stern Y. Association between the APOE genotype and psychopathologic symptoms in Alzheimer's disease. Neurology. 58: 1182-8. PMID 11971084 DOI: 10.1212/Wnl.58.8.1182 |
0.416 |
|
2002 |
Albert MS. Memory decline: the boundary between aging and age-related disease. Annals of Neurology. 51: 282-4. PMID 11891821 DOI: 10.1002/Ana.10156 |
0.302 |
|
2002 |
Sperling R, Greve D, Dale A, Killiany R, Holmes J, Rosas HD, Cocchiarella A, Firth P, Rosen B, Lake S, Lange N, Routledge C, Albert M. Functional MRI detection of pharmacologically induced memory impairment. Proceedings of the National Academy of Sciences of the United States of America. 99: 455-60. PMID 11756667 DOI: 10.1073/Pnas.012467899 |
0.477 |
|
2001 |
McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Archives of Neurology. 58: 1803-9. PMID 11708987 DOI: 10.1001/Archneur.58.11.1803 |
0.374 |
|
2001 |
Sperling RA, Bates JF, Cocchiarella AJ, Schacter DL, Rosen BR, Albert MS. Encoding novel face-name associations: a functional MRI study. Human Brain Mapping. 14: 129-39. PMID 11559958 DOI: 10.1002/Hbm.1047 |
0.464 |
|
2001 |
Ramos LR, Simoes EJ, Albert MS. Dependence in activities of daily living and cognitive impairment strongly predicted mortality in older urban residents in Brazil: a 2-year follow-up. Journal of the American Geriatrics Society. 49: 1168-75. PMID 11559375 DOI: 10.1046/J.1532-5415.2001.49233.X |
0.353 |
|
2001 |
Seeman TE, Lusignolo TM, Albert M, Berkman L. Social relationships, social support, and patterns of cognitive aging in healthy, high-functioning older adults: MacArthur studies of successful aging. Health Psychology. 20: 243-255. PMID 11515736 DOI: 10.1037/0278-6133.20.4.243 |
0.374 |
|
2001 |
Albert MS, Moss MB, Tanzi R, Jones K. Preclinical prediction of AD using neuropsychological tests. Journal of the International Neuropsychological Society : Jins. 7: 631-9. PMID 11459114 DOI: 10.1017/S1355617701755105 |
0.423 |
|
2001 |
Johnson KA, Lopera F, Jones K, Becker A, Sperling R, Hilson J, Londono J, Siegert I, Arcos M, Moreno S, Madrigal L, Ossa J, Pineda N, Ardila A, Roselli M, ... Albert MS, et al. Presenilin-1-associated abnormalities in regional cerebral perfusion. Neurology. 56: 1545-51. PMID 11402113 DOI: 10.1212/Wnl.56.11.1545 |
0.5 |
|
2001 |
Daly E, Komaroff AL, Bloomingdale K, Wilson S, Albert MS. Neuropsychological function in patients with chronic fatigue syndrome, multiple sclerosis, and depression. Applied Neuropsychology. 8: 12-22. PMID 11388119 DOI: 10.1207/S15324826An0801_3 |
0.32 |
|
2001 |
Sperling R, Greve D, Dale A, Killiany R, Rosen B, Holmes J, Rosas H, Cocchiarella A, Firth P, Lange N, Routledge C, Albert M. Effects of lorazepam and scopolamine on encoding face-name associations: A pharmacologic fMRI trial Neuroimage. 13: 743. DOI: 10.1016/S1053-8119(01)92085-3 |
0.464 |
|
2000 |
Collins JS, Perry RT, Watson B, Harrell LE, Acton RT, Blacker D, Albert MS, Tanzi RE, Bassett SS, McInnis MG, Campbell RD, Go RC. Association of a haplotype for tumor necrosis factor in siblings with late-onset Alzheimer disease: the NIMH Alzheimer Disease Genetics Initiative. American Journal of Medical Genetics. 96: 823-30. PMID 11121190 DOI: 10.1002/1096-8628(20001204)96:6<823::Aid-Ajmg26>3.0.Co;2-I |
0.36 |
|
2000 |
Albert MS, Drachman DA. Alzheimer's disease: what is it, how many people have it, and why do we need to know? Neurology. 55: 166-8. PMID 10908884 DOI: 10.1212/Wnl.55.2.166 |
0.456 |
|
2000 |
Grodstein F, Chen J, Pollen DA, Albert MS, Wilson RS, Folstein MF, Evans DA, Stampfer MJ. Postmenopausal hormone therapy and cognitive function in healthy older women. Journal of the American Geriatrics Society. 48: 746-52. PMID 10894312 DOI: 10.1111/J.1532-5415.2000.Tb04748.X |
0.372 |
|
2000 |
Johnson KA, Albert MS. Perfusion abnormalities in prodromal AD. Neurobiology of Aging. 21: 289-92. PMID 10867213 DOI: 10.1016/S0197-4580(00)00137-8 |
0.419 |
|
2000 |
Daly E, Zaitchik D, Copeland M, Schmahmann J, Gunther J, Albert M. Predicting conversion to Alzheimer disease using standardized clinical information. Archives of Neurology. 57: 675-80. PMID 10815133 DOI: 10.1001/Archneur.57.5.675 |
0.429 |
|
2000 |
Killiany RJ, Gomez-Isla T, Moss M, Kikinis R, Sandor T, Jolesz F, Tanzi R, Jones K, Hyman BT, Albert MS. Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease. Annals of Neurology. 47: 430-9. PMID 10762153 DOI: 10.1002/1531-8249(200004)47:4<430::Aid-Ana5>3.0.Co;2-I |
0.448 |
|
2000 |
Albert MS, Moss MB, Jones K. Early detection of Alzheimer's disease using neuropsychological testing Neurobiology of Aging. 21: 73. DOI: 10.1016/S0197-4580(00)82550-6 |
0.367 |
|
1999 |
Gómez-Tortosa E, Newell K, Irizarry MC, Albert M, Growdon JH, Hyman BT. Clinical and quantitative pathologic correlates of dementia with Lewy bodies. Neurology. 53: 1284-91. PMID 10522886 DOI: 10.1212/Wnl.53.6.1284 |
0.382 |
|
1999 |
Wilson RS, Beckett LA, Bennett DA, Albert MS, Evans DA. Change in cognitive function in older persons from a community population: relation to age and Alzheimer disease. Archives of Neurology. 56: 1274-9. PMID 10520945 DOI: 10.1001/Archneur.56.10.1274 |
0.463 |
|
1999 |
Jacobs DM, Albert SM, Sano M, del Castillo-Castañeda C, Paik MC, Marder K, Bell K, Brandt J, Albert MS, Stern Y. Assessment of cognition in advanced AD: the test for severe impairment. Neurology. 52: 1689-91. PMID 10331701 DOI: 10.1212/Wnl.52.8.1689 |
0.434 |
|
1999 |
Koff E, Zaitchik D, Montepare J, Albert MS. Emotion processing in the visual and auditory domains by patients with Alzheimer's disease. Journal of the International Neuropsychological Society : Jins. 5: 32-40. PMID 9989022 DOI: 10.1017/S1355617799511053 |
0.31 |
|
1999 |
Wilson RS, Beckett LA, Bennett DA, Albert MS, Evans DA. Change in cognitive function in older persons from a community population: Relation to age and Alzheimer disease Archives of Neurology. 56: 1274-1279. DOI: 10.1001/archneur.56.10.1274 |
0.358 |
|
1998 |
Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 51: 1546-54. PMID 9855500 DOI: 10.1212/Wnl.51.6.1546 |
0.322 |
|
1998 |
Liao A, Nitsch RM, Greenberg SM, Finckh U, Blacker D, Albert M, Rebeck GW, Gomez-Isla T, Clatworthy A, Binetti G, Hock C, Mueller-Thomsen T, Mann U, Zuchowski K, Beisiegel U, et al. Genetic association of an alpha2-macroglobulin (Val1000lle) polymorphism and Alzheimer's disease. Human Molecular Genetics. 7: 1953-6. PMID 9811940 DOI: 10.1093/Hmg/7.12.1953 |
0.376 |
|
1998 |
Mohs RC, Ashman TA, Jantzen K, Albert M, Brandt J, Gordon B, Rasmusson X, Grossman M, Jacobs D, Stern Y. A study of the efficacy of a comprehensive memory enhancement program in healthy elderly persons. Psychiatry Research. 77: 183-95. PMID 9707301 DOI: 10.1016/S0165-1781(98)00003-1 |
0.306 |
|
1998 |
Blacker D, Wilcox MA, Laird NM, Rodes L, Horvath SM, Go RC, Perry R, Watson B, Bassett SS, McInnis MG, Albert MS, Hyman BT, Tanzi RE. Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nature Genetics. 19: 357-60. PMID 9697696 DOI: 10.1038/1243 |
0.372 |
|
1998 |
Johnson KA, Jones K, Holman BL, Becker JA, Spiers PA, Satlin A, Albert MS. Preclinical prediction of Alzheimer's disease using SPECT. Neurology. 50: 1563-71. PMID 9633695 DOI: 10.1212/Wnl.50.6.1563 |
0.435 |
|
1997 |
Go RC, Duke LW, Harrell LE, Cody H, Bassett SS, Folstein MF, Albert MS, Foster JL, Sharrow NA, Blacker D. Development and validation of a Structured Telephone Interview for Dementia Assessment (STIDA): the NIMH Genetics Initiative. Journal of Geriatric Psychiatry and Neurology. 10: 161-7. PMID 9453683 DOI: 10.1177/089198879701000407 |
0.439 |
|
1997 |
Albert MS. The ageing brain: normal and abnormal memory. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 352: 1703-9. PMID 9415922 DOI: 10.1098/Rstb.1997.0152 |
0.389 |
|
1997 |
Evans DA, Hebert LE, Beckett LA, Scherr PA, Albert MS, Chown MJ, Pilgrim DM, Taylor JO. Education and other measures of socioeconomic status and risk of incident Alzheimer disease in a defined population of older persons. Archives of Neurology. 54: 1399-405. PMID 9362989 DOI: 10.1001/Archneur.1997.00550230066019 |
0.371 |
|
1997 |
Albert SM, Sano M, Marder K, Jacobs DM, Brandt J, Albert M, Stern Y. Participation in clinical trials and long-term outcomes in Alzheimer's disease. Neurology. 49: 38-43. PMID 9222167 DOI: 10.1212/Wnl.49.1.38 |
0.339 |
|
1997 |
Stern Y, Brandt J, Albert M, Jacobs DM, Liu X, Bell K, Marder K, Sano M, Albert S, Del-Castillo Castenada C, Bylsma F, Tycko B, Mayeux R. The absence of an apolipoprotein epsilon4 allele is associated with a more aggressive form of Alzheimer's disease. Annals of Neurology. 41: 615-20. PMID 9153523 DOI: 10.1002/Ana.410410510 |
0.401 |
|
1997 |
Costa P.T. J, Williams TF, Albert MS, Butters NM, Folstein MF, Gilman S, Gurland BJ, Gwyther LP, Heyman A, Kaszniak AW, Katz IR, Lanska D, Levy LL, Lombardo NE, Orr-Rainey NK, et al. Early identification of Alzheimer's disease and related dementias American Family Physician. 55: 1303-1314. PMID 9092291 DOI: 10.1111/j.1745-7599.1997.tb01024.x |
0.305 |
|
1997 |
Devanand DP, Jacobs DM, Tang MX, Del Castillo-Castaneda C, Sano M, Marder K, Bell K, Bylsma FW, Brandt J, Albert M, Stern Y. The course of psychopathologic features in mild to moderate Alzheimer disease. Archives of General Psychiatry. 54: 257-63. PMID 9075466 DOI: 10.1001/Archpsyc.1997.01830150083012 |
0.378 |
|
1997 |
Albert MS. The science of the mind. Science (New York, N.Y.). 275: 1547. PMID 9072814 DOI: 10.1126/Science.275.5306.1547 |
0.461 |
|
1997 |
Stern Y, Tang MX, Albert MS, Brandt J, Jacobs DM, Bell K, Marder K, Sano M, Devanand D, Albert SM, Bylsma F, Tsai WY. Predicting time to nursing home care and death in individuals with Alzheimer disease. Jama. 277: 806-12. PMID 9052710 DOI: 10.1001/Jama.1997.03540340040030 |
0.336 |
|
1997 |
Blacker D, Haines JL, Rodes L, Terwedow H, Go RC, Harrell LE, Perry RT, Bassett SS, Chase G, Meyers D, Albert MS, Tanzi R. ApoE-4 and age at onset of Alzheimer's disease: the NIMH genetics initiative. Neurology. 48: 139-47. PMID 9008509 DOI: 10.1212/Wnl.48.1.139 |
0.421 |
|
1996 |
Albert MS. Cognitive and neurobiologic markers of early Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America. 93: 13547-51. PMID 8942970 DOI: 10.1073/Pnas.93.24.13547 |
0.478 |
|
1996 |
Stern Y, Liu X, Albert M, Brandt J, Jacobs DM, Del Castillo-Castaneda C, Marder K, Bell K, Sano M, Bylsma F. Modeling the influence of extrapyramidal signs on the progression of Alzheimer disease. Archives of Neurology. 53: 1121-6. PMID 8912485 DOI: 10.1001/Archneur.1996.00550110061013 |
0.378 |
|
1996 |
Albert SM, Del Castillo-Castaneda C, Sano M, Jacobs DM, Marder K, Bell K, Bylsma F, Lafleche G, Brandt J, Albert M, Stern Y. Quality of life in patients with Alzheimer's disease as reported by patient proxies. Journal of the American Geriatrics Society. 44: 1342-7. PMID 8909350 DOI: 10.1111/J.1532-5415.1996.Tb01405.X |
0.303 |
|
1996 |
Marcel B, Komaroff AL, Fagioli LR, Kornish RJ, Albert MS. Cognitive deficits in patients with chronic fatigue syndrome. Biological Psychiatry. 40: 535-41. PMID 8879474 DOI: 10.1016/0006-3223(95)00422-X |
0.318 |
|
1996 |
Matsumae M, Kikinis R, Mórocz I, Lorenzo AV, Albert MS, Black PM, Jolesz FA. Intracranial compartment volumes in patients with enlarged ventricles assessed by magnetic resonance-based image processing. Journal of Neurosurgery. 84: 972-81. PMID 8847592 DOI: 10.3171/Jns.1996.84.6.0972 |
0.328 |
|
1996 |
Peters A, Rosene DL, Moss MB, Kemper TL, Abraham CR, Tigges J, Albert MS. Neurobiological bases of age-related cognitive decline in the rhesus monkey. Journal of Neuropathology and Experimental Neurology. 55: 861-74. PMID 8759775 DOI: 10.1097/00005072-199608000-00001 |
0.367 |
|
1996 |
Ott BR, Lafleche G, Whelihan WM, Buongiorno GW, Albert MS, Fogel BS. Impaired awareness of deficits in Alzheimer disease. Alzheimer Disease and Associated Disorders. 10: 68-76. PMID 8727167 DOI: 10.1097/00002093-199601020-00003 |
0.483 |
|
1996 |
Stern Y, Liu X, Albert M, Brandt J, Jacobs DM, Del Castillo-Castaneda C, Marder K, Bell K, Sano M, Bylsma F, Lafleche G, Tsai WY. Application of a growth curve approach to modeling the progression of Alzheimer's disease. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 51: M179-84. PMID 8681001 DOI: 10.1093/Gerona/51A.4.M179 |
0.409 |
|
1995 |
Albert MS, Jones K, Savage CR, Berkman L, Seeman T, Blazer D, Rowe JW. Predictors of cognitive change in older persons: MacArthur studies of successful aging. Psychology and Aging. 10: 578-89. PMID 8749585 DOI: 10.1037//0882-7974.10.4.578 |
0.368 |
|
1995 |
Stern Y, Albert M, Brandt J, Jacobs DM, Tang MX, Marder K, Bell K, Sano M, Devanand DP, Bylsma F. Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease: prospective analyses from the Predictors Study. Neurology. 44: 2300-7. PMID 7991116 DOI: 10.1212/Wnl.44.12.2300 |
0.424 |
|
1995 |
Marder K, Richards M, Bello J, Bell K, Sano M, Miller L, Folstein M, Albert M, Stern Y. Clinical correlates of Alzheimer's disease with and without silent radiographic abnormalities. Archives of Neurology. 52: 146-51. PMID 7848122 DOI: 10.1001/Archneur.1995.00540260050015 |
0.405 |
|
1995 |
Albert MS. How does education affect cognitive function? Annals of Epidemiology. 5: 76-8. PMID 7728289 DOI: 10.1016/1047-2797(94)00044-T |
0.329 |
|
1995 |
Hebert LE, Scherr PA, Beckett LA, Albert MS, Pilgrim DM, Chown MJ, Funkenstein HH, Evans DA. Age-specific incidence of Alzheimer's disease in a community population. Jama. 273: 1354-9. PMID 7715060 DOI: 10.1001/Jama.1995.03520410048025 |
0.375 |
|
1995 |
Duffy FH, McAnulty GB, Albert MS. Temporoparietal electrophysiological differences characterize patients with Alzheimer's disease: a split-half replication study. Cerebral Cortex (New York, N.Y. : 1991). 5: 215-21. PMID 7613077 DOI: 10.1093/Cercor/5.3.215 |
0.441 |
|
1995 |
Cook NR, Albert MS, Berkman LF, Blazer D, Taylor JO, Hennekens CH. Interrelationships of peak expiratory flow rate with physical and cognitive function in the elderly: MacArthur Foundation studies of aging. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 50: M317-23. PMID 7583803 DOI: 10.1093/Gerona/50A.6.M317 |
0.373 |
|
1995 |
Sano M, Devanand DP, Richards M, Miller LW, Marder K, Bell K, Dooneief G, Bylsma FW, Lafleche G, Albert M. A standardized technique for establishing onset and duration of symptoms of Alzheimer's disease. Archives of Neurology. 52: 961-6. PMID 7575223 DOI: 10.1001/Archneur.1995.00540340045012 |
0.385 |
|
1995 |
Lafleche G, Albert MS. Executive function deficits in mild Alzheimer's disease. Neuropsychology (Journal). 9: 313-320. DOI: 10.1037/0894-4105.9.3.313 |
0.404 |
|
1995 |
Albert MS. Aging, dementia and memory Journal of the Neurological Sciences. 134: 4. DOI: 10.1016/0022-510X(96)80081-5 |
0.332 |
|
1994 |
Seeman TE, Charpentier PA, Berkman LF, Tinetti ME, Guralnik JM, Albert M, Blazer D, Rowe JW. Predicting Changes in Physical Performance in a High-Functioning Elderly Cohort: MacArthur Studies of Successful Aging The Journals of Gerontology. 49. PMID 8169338 DOI: 10.1093/Geronj/49.3.M97 |
0.307 |
|
1994 |
Stern Y, Albert SM, Sano M, Richards M, Miller L, Folstein M, Albert M, Bylsma FW, Lafleche G. Assessing patient dependence in Alzheimer's disease. Journal of Gerontology. 49: M216-22. PMID 8056940 DOI: 10.1093/Geronj/49.5.M216 |
0.454 |
|
1994 |
Jacobs D, Sano M, Marder K, Bell K, Bylsma F, Lafleche G, Albert M, Brandt J, Stern Y. Age at onset of Alzheimer's disease: relation to pattern of cognitive dysfunction and rate of decline. Neurology. 44: 1215-20. PMID 8035918 DOI: 10.1212/Wnl.44.7.1215 |
0.468 |
|
1994 |
Odenheimer GL, Beaudet M, Jette AM, Albert MS, Grande L, Minaker KL. Performance-based driving evaluation of the elderly driver: safety, reliability, and validity. Journal of Gerontology. 49: M153-9. PMID 8014389 DOI: 10.1093/Geronj/49.4.M153 |
0.36 |
|
1994 |
Blacker D, Albert MS, Bassett SS, Go RC, Harrell LE, Folstein MF. Reliability and validity of NINCDS-ADRDA criteria for Alzheimer's disease. The National Institute of Mental Health Genetics Initiative. Archives of Neurology. 51: 1198-204. PMID 7986174 DOI: 10.1001/Archneur.1994.00540240042014 |
0.387 |
|
1994 |
Killiany RJ, Moss MB, Albert MS. Discriminant Analysis of Alzheimer's Disease-Reply Archives of Neurology. 51: 1088-1089. DOI: 10.1001/Archneur.1994.00540230026007 |
0.395 |
|
1993 |
Herbert LE, Scherr PA, Beckett LA, Albert MS, Rosner B, Taylor JO, Evans DA. Relation of smoking and low-to-moderate alcohol consumption to change in cognitive function: a longitudinal study in a defined community of older persons. American Journal of Epidemiology. 137: 881-91. PMID 8484379 DOI: 10.1093/Oxfordjournals.Aje.A116749 |
0.322 |
|
1993 |
Richards M, Folstein M, Albert M, Miller L, Bylsma F, Lafleche G, Marder K, Bell K, Sano M, Devanand D. Multicenter study of predictors of disease course in Alzheimer disease (the "predictors study"). II. Neurological, psychiatric, and demographic influences on baseline measures of disease severity. Alzheimer Disease and Associated Disorders. 7: 22-32. PMID 8481223 DOI: 10.1097/00002093-199307010-00003 |
0.325 |
|
1993 |
Albert M, Jenike M, Nixon R, Nobel K. Thyrotropin response to thyrotropin-releasing hormone in patients with dementia of the Alzheimer type. Biological Psychiatry. 33: 267-71. PMID 8471680 DOI: 10.1016/0006-3223(93)90293-M |
0.315 |
|
1993 |
Funkenstein HH, Albert MS, Cook NR, West CG, Scherr PA, Chown MJ, Pilgrim D, Evans DA. Extrapyramidal signs and other neurologic findings in clinically diagnosed Alzheimer's disease. A community-based study. Archives of Neurology. 50: 51-6. PMID 8418800 DOI: 10.1001/Archneur.1993.00540010045016 |
0.449 |
|
1993 |
Berkman LF, Seeman TE, Albert M, Blazer D, Kahn R, Mohs R, Finch C, Schneider E, Cotman C, McClearn G, Nesselroade J, Featherman D, Garmezy N, McKhann G, Brim G, et al. High, usual and impaired functioning in community-dwelling older men and women: Findings from the MacArthur Foundation Research Network on successful aging Journal of Clinical Epidemiology. 46: 1129-1140. PMID 8410098 DOI: 10.1016/0895-4356(93)90112-E |
0.35 |
|
1993 |
Killiany RJ, Moss MB, Albert MS, Sandor T, Tieman J, Jolesz F. Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease. Archives of Neurology. 50: 949-54. PMID 8363449 DOI: 10.1001/Archneur.1993.00540090052010 |
0.452 |
|
1993 |
Duffy FH, McAnulty GB, Jones K, Als H, Albert M. Brain electrical correlates of psychological measures: Strategies and problems Brain Topography. 5: 399-412. PMID 8357715 DOI: 10.1007/Bf01128698 |
0.332 |
|
1993 |
Inouye SK, Albert MS, Mohs R, Sun K, Berkman LF. Cognitive performance in a high-functioning community-dwelling elderly population. Journal of Gerontology. 48: M146-51. PMID 8315227 DOI: 10.1093/Geronj/48.4.M146 |
0.39 |
|
1993 |
Evans DA, Beckett LA, Albert MS, Hebert LE, Scherr PA, Funkenstein HH, Taylor JO. Level of education and change in cognitive function in a community population of older persons. Annals of Epidemiology. 3: 71-7. PMID 8287159 DOI: 10.1016/1047-2797(93)90012-S |
0.367 |
|
1993 |
Seeman TE, Rodin J, Albert M. Self-efficacy and cognitive performance in high-functioning older individuals: MacArthur studies of successful aging Journal of Aging and Health. 5: 455-474. DOI: 10.1177/089826439300500403 |
0.35 |
|
1992 |
Albert M, Cohen C. The Test for Severe Impairment: An Instrument for the Assessment of Patients with Severe Cognitive Dysfunction Journal of the American Geriatrics Society. 40: 449-453. PMID 1634695 DOI: 10.1111/J.1532-5415.1992.Tb02009.X |
0.37 |
|
1992 |
Sandor T, Jolesz F, Tieman J, Kikinis R, Jones K, Albert M. Comparative analysis of computed tomographic and magnetic resonance imaging scans in Alzheimer patients and controls. Archives of Neurology. 49: 381-4. PMID 1558519 DOI: 10.1001/Archneur.1992.00530280069024 |
0.308 |
|
1992 |
Hebert LE, Scherr PA, Beckett LA, Funkenstein HH, Albert MS, Chown MJ, Evans DA. Relation of smoking and alcohol consumption to incident Alzheimer's disease. American Journal of Epidemiology. 135: 347-55. PMID 1550089 DOI: 10.1093/Oxfordjournals.Aje.A116296 |
0.356 |
|
1992 |
Davis PC, Gray L, Albert M, Wilkinson W, Hughes J, Heyman A, Gado M, Kumar AJ, Destian S, Lee C, Duvall E, Kido D, Nelson MJ, Bello J, Weathers S, et al. The Consortium to Establish a Registry for Alzheimer's disease (CERAD) Part III. Reliability of a standardized MRI evaluation of Alzheimer's disease Neurology. 42: 1676-1680. PMID 1513454 DOI: 10.1212/Wnl.42.9.1676 |
0.427 |
|
1992 |
Duffy FH, Jones K, Bartels P, McAnulty G, Albert M. Unrestricted principal components analysis of brain electrical activity: Issues of data dimensionality, artifact, and utility Brain Topography. 4: 291-307. PMID 1510873 DOI: 10.1007/Bf01135567 |
0.303 |
|
1991 |
Albert MS, Lafleche G. Neuroimaging in Alzheimer's disease. The Psychiatric Clinics of North America. 14: 443-59. PMID 2062727 DOI: 10.1016/S0193-953X(18)30317-4 |
0.329 |
|
1991 |
Albert M, Smith LA, Scherr PA, Taylor JO, Evans DA, Funkenstein HH. Use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer's disease. International Journal of Neuroscience. 57: 167-178. PMID 1938160 DOI: 10.3109/00207459109150691 |
0.468 |
|
1991 |
Albert MS, Cohen C, Koff E. Perception of affect in patients with dementia of the Alzheimer type. Archives of Neurology. 48: 791-5. PMID 1898252 DOI: 10.1001/Archneur.1991.00530200027013 |
0.38 |
|
1991 |
Evans DA, Smith LA, Scherr PA, Albert MS, Funkenstein HH, Hebert LE. Risk of death from Alzheimer's disease in a community population of older persons. American Journal of Epidemiology. 134: 403-12. PMID 1877601 DOI: 10.1093/Oxfordjournals.Aje.A116102 |
0.457 |
|
1991 |
Jones KJ, Albert MS, Duffy FH, Hyde MR, Naeser M, Aldwin C. Modeling age using cognitive, psychosocial and physiological variables: the Boston Normative Aging Study. Experimental Aging Research. 17: 227-42. PMID 1820288 DOI: 10.1080/03610739108253900 |
0.358 |
|
1990 |
Albert MS, Duffy FH, McAnulty GB. Electrophysiologic comparisons between two groups of patients with Alzheimer's disease. Archives of Neurology. 47: 857-63. PMID 2375691 DOI: 10.1001/Archneur.1990.00530080039008 |
0.396 |
|
1990 |
Albert MS, Wolfe J, Lafleche G. Differences in abstraction ability with age. Psychology and Aging. 5: 94-100. PMID 2317307 DOI: 10.1037//0882-7974.5.1.94 |
0.304 |
|
1990 |
Jenike MA, Albert MS, Baer L. Oral physostigmine as treatment for dementia of the Alzheimer type: a long-term outpatient trial. Alzheimer Disease and Associated Disorders. 4: 226-31. PMID 2264980 DOI: 10.1097/00002093-199040400-00004 |
0.337 |
|
1990 |
Jenike MA, Albert M, Baer L, Gunther J. Oral physostigmine as treatment for primary degenerative dementia: a double-blind placebo-controlled inpatient trial. Journal of Geriatric Psychiatry and Neurology. 3: 13-16. PMID 2189429 DOI: 10.1177/089198879000300104 |
0.373 |
|
1990 |
Evans DA, Funkenstein HH, Cook NR, Hennekens CH, Taylor JO, Albert MS, Scherr PA, Chown MJ, Hebert LE. The Presence of Alzheimer's Disease in a Community Population-Reply Jama. 263: 2448-2449. DOI: 10.1001/Jama.1990.03440180045023 |
0.392 |
|
1989 |
Evans DA, Funkenstein HH, Albert MS, Scherr PA, Cook NR, Chown MJ, Hebert LE, Hennekens CH, Taylor JO. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. Jama. 262: 2551-6. PMID 2810583 DOI: 10.1001/Jama.1989.03430180093036 |
0.415 |
|
1989 |
Milberg W, Albert M. Cognitive differences between patients with progressive supranuclear palsy and Alzheimer's disease. Journal of Clinical and Experimental Neuropsychology. 11: 605-14. PMID 2808652 DOI: 10.1080/01688638908400919 |
0.445 |
|
1989 |
Albert M, Milberg W. Semantic processing in patients with Alzheimer's disease. Brain and Language. 37: 163-71. PMID 2752272 DOI: 10.1016/0093-934X(89)90106-5 |
0.361 |
|
1988 |
Scherr PA, Albert MS, Funkenstein HH, Cook NR, Hennekens CH, Branch LG, White LR, Taylor JO, Evans DA. Correlates of cognitive function in an elderly community population. American Journal of Epidemiology. 128: 1084-101. PMID 3189282 DOI: 10.1093/Oxfordjournals.Aje.A115051 |
0.372 |
|
1987 |
Mayeux R, Albert M, Jenike M. Physostigmine‐induced myoclonus in Alzheimer's disease Neurology. 37: 345-345. PMID 3808321 DOI: 10.1212/Wnl.37.2.345 |
0.328 |
|
1987 |
Duffy FH, McAnulty G, Albert M, Durwen H, Weintraub S. Lecithin: absence of neurophysiologic effect in Alzheimer's disease by EEG topography. Neurology. 37: 1015-9. PMID 3587619 DOI: 10.1212/Wnl.37.6.1015 |
0.319 |
|
1986 |
LeMay M, Stafford JL, Sandor T, Albert M, Haykal H, Zamani A. Statistical assessment of perceptual CT scan ratings in patients with Alzheimer type dementia. Journal of Computer Assisted Tomography. 10: 802-9. PMID 3489017 DOI: 10.1097/00004728-198609000-00018 |
0.381 |
|
1986 |
Moss MB, Albert MS, Butters N, Payne M. Differential patterns of memory loss among patients with Alzheimer's disease, Huntington's disease, and alcoholic Korsakoff's syndrome. Archives of Neurology. 43: 239-46. PMID 2936323 DOI: 10.1001/Archneur.1986.00520030031008 |
0.414 |
|
1985 |
Holman BL, Gibson RE, Hill TC, Eckelman WC, Albert M, Reba RC. Muscarinic Acetylcholine Receptors in Alzheimer's Disease: In Vivo Imaging With Iodine 123—Labeled 3-Quinuclidinyl-4-Iodobenzilate and Emission Tomography Jama: the Journal of the American Medical Association. 254: 3063-3066. DOI: 10.1001/Jama.1985.03360210079035 |
0.331 |
|
1984 |
Jenike MA, Albert MS. The dexamethasone suppression test in patients with presenile and senile dementia of the Alzheimer's type. Journal of the American Geriatrics Society. 32: 441-4. PMID 6725805 DOI: 10.1111/J.1532-5415.1984.Tb02220.X |
0.417 |
|
1984 |
Albert M. Assessment of cognitive function in the elderly Psychosomatics. 25: 310-313, 316. PMID 6718665 DOI: 10.1016/S0033-3182(84)73048-9 |
0.383 |
|
1984 |
Vitaliano PP, Breen AR, Albert MS, Russo J, Prinz PN. Memory, attention, and functional status in community-residing Alzheimer type dementia patients and optimally healthy aged individuals. Journal of Gerontology. 39: 58-64. PMID 6690588 DOI: 10.1093/Geronj/39.1.58 |
0.31 |
|
1984 |
Vitaliano PP, Breen AR, Russo J, Albert M, Vitiello MV, Prinz PN. The clinical utility of the dementia rating scale for assessing Alzheimer patients. Journal of Chronic Diseases. 37: 743-53. PMID 6501546 DOI: 10.1016/0021-9681(84)90043-2 |
0.411 |
|
1984 |
Albert M, Naeser MA, Levine HL, Garvey AJ. CT density numbers in patients with senile dementia of the Alzheimer's type. Archives of Neurology. 41: 1264-9. PMID 6497730 DOI: 10.1001/Archneur.1984.04050230046016 |
0.35 |
|
1984 |
Albert M, Naeser MA, Levine HL, Garvey AJ. Ventricular size in patients with presenile dementia of the Alzheimer's type. Archives of Neurology. 41: 1258-63. PMID 6497729 DOI: 10.1001/Archneur.1984.04050230040015 |
0.384 |
|
1984 |
Duffy FH, Albert MS, McAnulty G. Brain electrical activity in patients with presenile and senile dementia of the Alzheimer type. Annals of Neurology. 16: 439-48. PMID 6497353 DOI: 10.1002/Ana.410160404 |
0.384 |
|
1983 |
Weintraub S, Mesulam MM, Auty R, Baratz R, Cholakos BN, Kapust L, Ransil B, Tellers JG, Albert MS, LoCastro S, Moss M. Lecithin in the treatment of Alzheimer's disease. Archives of Neurology. 40: 527-8. PMID 6347143 DOI: 10.1001/Archneur.1983.04210070067022 |
0.537 |
|
1983 |
Butters N, Albert MS, Sax DS, Miliotis P, Nagode J, Sterste A. The effect of verbal mediators on the pictorial memory of brain-damaged patients. Neuropsychologia. 21: 307-23. PMID 6225962 DOI: 10.1016/0028-3932(83)90018-0 |
0.363 |
|
1981 |
Albert MS, Butters N, Brandt J. Development of remote memory loss in patients with Huntington's disease. Journal of Clinical Neuropsychology. 3: 1-12. PMID 6456280 DOI: 10.1080/01688638108403109 |
0.339 |
|
1981 |
Albert MS, Butters N, Brandt J. Patterns of remote memory in amnesic and demented patients. Archives of Neurology. 38: 495-500. PMID 6454407 DOI: 10.1001/Archneur.1981.00510080057008 |
0.315 |
|
Show low-probability matches. |